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ABSTRACT 
 
 Paratuberculosis is a disease caused by Mycobacterium avium subsp. 
paratuberculosis (MAP). This is a chronic enteric disease of ruminant animals with 
clinical signs taking from 2 to 5 years for manifestation. Current diagnostic tests are 
effective in identifying animals in later stages of infection; however, sensitivity among 
animals in the early stages of infection is low. In addition, currently available vaccines in 
the US fail to prevent infection of animals. Transitions in host immunity to MAP leading 
to clinical disease are poorly understood and their comprehension could lead to more 
targeted approaches for vaccine and diagnostic development. The objective of the first 
study was to identify protein complexes in the envelope of MAP to gain insight into 
pathogenic mechanisms as well as to identify antigenic proteins. Seven protein 
complexes were identified in the envelope of MAP and these complexes were 
fragmented into individual proteins with potential as diagnostic and vaccine targets. The 
second objective in this thesis was to study two crucial molecules in T cell signaling 
investigated in cows with subclinical and clinical disease. ZAP-70 (zeta-chain associated 
protein of 70 kDa) is involved in proximal T cell receptor signaling and its activation is 
necessary for T cell effector function. The second molecule studied was CTLA-4 
(cytotoxic T-lymphocyte antigen-4), regarded as one of the major negative regulators of 
T cell function. All MAP infected animals demonstrated a significant reduction in 
expression of ZAP-70 among CD4+ T cells whereas only animals of subclinical status 
had a significant upregulation of CTLA-4 in the CD4+ T cell population. Both studies 
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contribute novel and important findings to the field of paratuberculosis. Protein 
interactions within the envelope of MAP were discovered along with the identification 
of several protein candidates for vaccine and diagnostic development. In addition, 
immune alterations that occur with infection and progression of disease were also 
demonstrated.
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CHAPTER 1. GENERAL INTRODUCTION  
Introduction 
 Paratuberculosis, also known as Johne’s disease, is a major animal health burden 
to livestock worldwide. This is a chronic disease caused by Mycobacterium avium subsp. 
paratuberculosis (MAP) of which all ruminants are susceptible. The economic impact of 
the disease is highest among dairy cattle where it leads to decreased milk production, 
higher incidence of mastitis and lower fertility rates, contributing to premature culling of 
animals. The envelope of MAP is an important component of the bacterium, which 
contains the first antigens the host encounters upon infection. Therefore, this research 
project was focused upon understanding protein interactions among this compartment 
and in identifying proteins that have the potential to discriminate between non-infected 
and infected animals for the development of better diagnostic tools. The second research 
project addressed the immune response to MAP and possible alterations that occur 
within T cells during progression of the disease. T cells are a crucial part of the adaptive 
immune system and are necessary to effectively clear many infections, however little 
research has been done regarding T cell function or T cell signaling related to MAP 
infection. By analyzing ZAP-70 and CTLA-4, two crucial signaling molecules of T cells, 
differences in T cell phenotypes were investigated in animals of different disease states. 
In addition, by using phospho flow cytometry analysis, proximal T cell receptor 
signaling and ZAP-70 phosphorylation were also evaluated.  
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Thesis Organization 
 This thesis is organized into four chapters, two of which are papers intended for 
publication in peer-reviewed journals. The first chapter contains a general introduction 
to Johnes disease and a literature review describing what is known about the immune 
response to MAP.  This includes a survey of some important antigens and proteomic 
studies performed with the bacterium. The second chapter contains the paper entitled 
“Envelope protein complexes of Mycobacterium avium subsp. paratuberculosis and 
their antigenicity” which has been prepared for submission to the Journal of 
Bacteriology. Chapter three contains the paper “ ZAP-70, CTLA-4 and proximal T cell 
receptor signaling” and has been prepared for submission to the journal Infection and 
Immunity. Finally in chapter 4, the thesis finishes with a general conclusion and 
recommendations for future research. 
 
Literature Review 
 
 
Background 
Paratuberculosis, also called Johne’s disease, is a disease of ruminant animals 
caused by the bacterium Mycobacterium avium subsp. paratuberculosis (MAP). 
Paratuberculosis was described for the first time in 1895 by Dr. Heinrich Albert Johne 
and Dr. Herman Markus, who examined the intestines of a cow with a history of 
decreased milk production and weight loss (Manning & Collins, 2010). Initially, a 
diagnosis of intestinal tuberculosis was made due to the similarity of lesions, however, a 
sample of infected tissue failed to cause disease in guinea pigs. Upon further histological 
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examination, acid-fast bacteria were observed throughout the intestine and a conclusion 
was made that the disease was caused by an etiologic agent other than Mycobacterium 
tuberculosis (Johne & Frotihngham, 1895).  The etiologic agent was later characterized 
as Mycobacterium avium subsp. paratuberculosis (Thorel et al., 1990). 
Today, paratuberculosis has worldwide distribution, with varying prevalence 
among countries. In the US, it is estimated that a staggering 91% of dairy herds are 
infected with MAP (Lombard et al., 2013). The economic impact of Johne’s disease is 
due mainly to reduced milk production, increased incidence of mastitis and early culling 
of animals (Lombard, 2011). Within an infected herd most animals would be in the 
subclinical stage of infection with decreased production parameters and no clinical signs 
of infection (Magombedze et al., 2013). As disease progresses, taking from 2-5 years, 
animals demonstrate clinical signs of disease which include emaciation and chronic or 
intermittent diarrhea, eventually leading to death (Stabel, 1998).  
 Although there are assays available to diagnose MAP infection as well as 
commercial vaccines, neither is completely effective (Patton, 2011; Facciuolo et al., 
2013). Current diagnostic tests, such as ELISAs, are ineffective in detection of animals 
in subclinical stage of infection (Facciuolo et al., 2013). The vaccine currently licensed 
for use in the US lowers shedding of the organism and reduces clinical signs, however, 
prevention of infection is not achieved (Patton, 2011). 
With this in mind, research is still needed to identify potential candidates for use 
in improving diagnostic assays and vaccines (Bannantine et al., 2010). Another major 
area of research that requires further work is the study of the host immune response to 
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MAP infection, in particular, those immunologic changes that occur as an animal 
progresses from subclinical to clinical disease states (Stabel, 2006). Research focused in 
these fields is required to achieve a better understanding of the disease and develop more 
targeted approaches for controlling and preventing paratuberculosis. 
 
Infection and immune response to MAP  
Infection by MAP occurs mainly by the fecal-oral route. This may occur by 
direct ingestion of MAP contaminated feces as well as by ingestion of milk and 
colostrum from infected dams, in addition to contaminated water and feed (Fecteau & 
Whitlock, 2010). Infection of the fetus has also been described in infected dams 
(Whittington & Windor, 2009). After entering the host, at the small intestine, MAP 
enters the submucosa aided by microfold cells (M cells) within the Peyer’s patches 
(Momotani et al., 1988). MAP also has the ability to enter the host intestinal mucosa 
through enterocytes (Pott et al., 2009; Bermudez et al., 2010). It has been proposed that 
targeting and invasion of M cells is mediated by the formation of a fibronectin bridge 
between a fibronectin attachment protein of MAP and integrins on M cells (Secott et al., 
2004). Other proteins that have also been implicated in invasion of the intestine by MAP 
include major membrane protein (Bannantine et al., 2003) was well as ModD, a 
fibronectin attachment protein, and proteins of the antigen 85 complex which are also 
fibronectin attachment proteins (Bannantine & Bermudez, 2013). Upon uptake by the M 
cells, MAP is transported to the submucosal side of the intestinal epithelium where it is 
taken up by macrophages.  
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MAP is an obligate intracellular pathogen and once in macrophages it can 
prevent maturation and acidification of the phagosome thus avoiding antimicrobial 
components of the lysosome (Hostetter et al., 2003). The expression of MHC molecules 
has also been shown to be downregulated in infected macrophages along with higher 
induced expression of IL-10 and TGF-β (Weiss & Souza, 2008). Khalifeh & Stabel 
(2004) demonstrated that macrophages exposed in culture to exogenous IL-10 and TGF-
β significantly reduced their ability to kill MAP, suggesting these cytokines play an 
important role in infection, by limiting the bactericidal capabilities of macrophages. One 
of the virulence factors driving the increased survival of MAP has recently been 
described by Souza et al. (2013) who demonstrated that mannosylated 
lipoarabinomannan (Man-LAM), a glycolipid present in the envelope of MAP and other 
pathogenic mycobacteria, has the capacity to increase IL-10 production by macrophages 
as well as inhibit phagosome acidification, phagolysosome fusion, and reduce the killing 
of bacteria. 
  As Johne’s disease progresses from subclinical to clinical stages the host makes 
an effort to contain infection by the formation of granulomas, similar to what occurs in 
other mycobacterial diseases (Gonzalez et al., 2005). In the early stages of disease and 
before the onset of clinical signs, granuloma formation leads to minimal lesions, 
localized in the intestine or lymph nodes. As the disease progresses, shedding of the 
bacteria occurs and intestinal lesions become more severe (Sweeney, 2011; Gonzalez et 
al., 2005). Due to cellular infiltration of macrophages and granulomatous inflammation 
in the intestine, malabsorption occurs leading to the clinical signs of diarrhea and 
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progressive weight loss (Sweeney, 2011). Animals can remain in a subclinical stage of 
infection for up to 2-5 years before the onset of clinical signs (Stabel, 1998).  For 
unknown reasons, some animals never progress on to clinical disease. 
In the early stages, the disease is controlled by a cell-mediated Th1 response 
where T cells activated by infected macrophages express Th1-associated cytokines, IFN-
γ, IL-2 and TNF-α (Stabel, 2006).  IFN-γ is a key molecule that helps in the activation of 
macrophages with the production of reactive oxygen and nitrogen species, activation of 
T cells, and maturation of DCs (He et al., 2007). Another important role for IFN-γ is the 
induction of IL-12 which further directs CD4+ cells to the Th1 subset. Studies have 
demonstrated that CD4+ cells are the primary source of IFN-γ in MAP infection (Stabel, 
2010).  
As the disease progresses and clinical manifestations begin to appear, there is a 
shift in the observed immune response. The Th1 response wanes as a Th2 type response 
rises that is characterized by the cytokines IL-4, IL-5 and IL-10 (Stabel, 2000; Stabel, 
2006). The cause for this transition is unknown, and the Th2 response is not protective 
(Stabel 2000; Stabel, 2010). Khalifeh & Stabel (2004b) studied the dynamics of IL-10, 
TGF-β and IFN-γ gene expression in the ileum, ileocecal junction, ileocecal lymph node, 
and mesenteric lymph nodes of healthy cows as well as those in subclinical and clinical 
stages of infection. IL-10 levels were significantly higher in all tissues of cows with 
clinical disease and TGF-β mRNA was also higher among these animals. Healthy 
animals and those with subclinical disease expressed similar levels of these cytokines. In 
contrast, IFN-γ gene expression was significantly higher only among animals with 
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subclinical infection with no differences observed between healthy animals and those 
with clinical disease. This demonstrates clear immune differences among these three 
states and suggests that altered cytokine expression is related to advanced clinical 
disease. The importance of these cytokines as well as the consequences of changes in 
their expression have been demonstrated by studies finding that neutralization of IL-10 
can increase the killing of MAP by bovine macrophages (Weiss et al., 2005) as well as 
lead to increased IFN-γ production by as much as 23-fold (Buza et al., 2004).  
 
Evidence and possible correlation to T cell anergy/hypofunction and T regulatory 
cells. 
One possible explanation for the loss of effectiveness toward controlling 
infection mediated by a Th1 response is the development of anergy and/or T regulatory 
(Treg) cells. One mechanism potentially leading to anergy or induced Treg (iTreg) 
development is a reduction in co-stimulation provided by macrophages or an 
environment rich in Treg-inducing cytokines such as TGF-β (Schwartz, 2003). 
As mentioned earlier, IL-10 production is upregulated with the progression of 
disease (Khalifeh & Stabel, 2004b). There are few studies describing the involvement of 
Treg cells or anergy in relation to paratuberculosis. However, some recent evidence 
suggests a role for Tregs in progression of the disease (de Ameida et al., 2008; Coussens 
et al., 2012). In one study, the removal of CD25+ CD4+ from a peripheral mononuclear 
cell preparation prior to stimulation with MAP antigen resulted in a decrease of IL-10 
expression, suggesting an important role for these cells. Considering that Treg cells 
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would be induced in infected animals, the same study measured the percentage of Tregs 
in the peripheral blood mononuclear cells (PBMCs) of infected and control non-infected 
cattle. Results demonstrated CD4+ CD25+ cells were present in significantly greater 
proportion in infected animals (de Almeida et al., 2008).  
Providing evidence towards anergy, Weiss et al. (2006) studied the phenotype 
and response of mononuclear leukocytes from the ileum of cows naturally infected with 
MAP. Lymphocytes isolated from the ileum of infected cows did not proliferate when 
incubated with MAP antigen, demonstrating a hyporesponsive state of these cells (Weiss 
et al., 2006). In a study to investigate the immune response to MAP in sheep, Begg et al. 
(2011) similarly observed that animals in more advanced stages of disease had non 
responsive T cells. Multibacillary sheep demonstrated decreased IFN-γ production 
among PBMCs and reduced ability to proliferate in response to MAP antigen and 
pokeweed mitogen. IL-12 was added to the cell culture in an attempt to aid their 
activation, however, addition of the cytokine had no significant effect on cellular 
responses, which may suggest a greater inhibition of these cells (Begg et al. 2011). More 
recently, Khare et al. (2012) studied the gene expression of ligated ileal loops in neonatal 
calves infected with MAP. This was in an effort to comprehend the early immune 
responses that lead to immune tolerance in subclinical animals. Some genes related to T 
cell signaling were not altered but others such as the transcription factors NFATC4 
(nuclear factor of activated T-cells C4) and NFATC1 (nuclear factor of activated T-cells 
C1) were. These transcription factors are related to expression of IL-2 and other gene 
products important for activation, proliferation and differentiation of T-cells as well as 
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lymphoid and non-lymphoid cells. This demonstrates that alterations of the normal 
signaling events of the T cell during infection may occur, possibly contributing to the 
lesser function of these cells (Khare et al., 2012). Regarding B cells and possible anergy 
induction, Waters et al. (1999) studied the proliferative response of B cells to 
concanvalin A and MAP antigen in clinical and subclnical animals. It was demonstrated 
that B cells of animals in clinical stage of disease were unresponsive and did not 
proliferate upon antigen stimulation, in contrast to animals with subclinical disease 
which had proliferative responses to MAP antigen. This demonstrated that B cells of 
animals in clinical stage of disease are also altered and respond less to stimulation. 
 
T cell activation and roles of ZAP-70 and CTLA-4  
As mentioned earlier, T cells are an important component of the immune 
response to MAP infection, thus the study of these cells and especially their activation is 
important in identifying potential alterations that occur with the progression of disease, 
leading to clinical signs and eventual death of the animal.  
Activation of the T cell occurs by the recognition of a presented antigen in 
conjunction with a major histocompatibility class (MHC) molecule. For CD4+ cells this 
is an MHC class II molecule while for CD8+ cells this is a MHC class I molecule. These 
MHC molecules once associated with a peptide, are recognized by the T cell receptor 
(TCR). Along with the TCR is the associated CD3 complex comprised of CD3γ, CD3δ, 
CD3ε and CD3ζ chains (Murphy, 2012). When presenting antigens to T cells, antigen 
presenting cells (APC) also engage a co-receptor in the T cell, CD28, with the ligands 
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B7.1 (CD80) and B7.2 (CD86) (Walker & Sansom, 2011). This engagement is necessary 
to prime naïve cells as well as inhibit anergy by stabilizing mRNA expression and 
induction of survival signals such as IL-2 production by AP-1 transcription factor 
activation (Rudd et al., 2009). Signaling leading to T cell activation is initiated by 
tyrosine phosphorylation within the cytoplasmic regions of the CD3 chains in regions 
called immuno-receptor tyrosine-based activation motifs (ITAMs). Specifically, ITAMs 
present in the CD3ζ chains become phosphorylated by the tyrosine kinase Lck 
(lymphocyte-specific protein tyrosine kinase) that is constitutively associated with the 
cytoplasmic domains of the CD4 or CD8 co-receptor. When the co-receptor (CD4 or 
CD8) binds to the TCR:peptide:MHC complex, Lck is brought near the ITAMS and 
causes their phosphorylation. The molecule then responsible for carrying this signal 
forward for T cell activation is the ζ-chain associated protein of 70 kDa (ZAP-70) (Wang 
et al., 2010).  
Upon activation, phosphorylated ITAMs in the TCR complex recruit ZAP-70 
from the cytoplasm near the plasma membrane, where it is phosphorylated by Lck. 
ITAM binding and phosphorylation release ZAP-70 from an autoinhibited state in which 
it remains in inactivated cells (Wang et al., 2010). This enables ZAP-70 to phosphorylate 
two adaptor proteins, LAT (linker for the activation of T cells) and SLP-76 (Src 
homology 2 domain-containing leukocyte phosphoprotein of 76 kDa), leading to the 
recruitment of effector proteins that stimulate T cell activation (Murphy, 2012). The 
importance of ZAP-70 is evidenced by studies demonstrating that TCR signaling events 
are severely inhibited in Jurkat T cells lacking ZAP-70 (Williams et al., 1998). Also, loss 
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of ZAP-70 function results in severe combined immunodeficiency (SCID) in both 
humans and mice, which is characterized by a lack of functional peripheral T cells 
(Elder, 2001). 
ZAP-70 is comprised of several tyrosine residues itself which need to be 
phosphorylated for its activation. Although critical, binding to ITAMs of the CD3ζ chain 
and perturbation of the auto-inhibitory conformation alone is insufficient for complete 
ZAP-70 activation (Jin et al., 2004). Phosphorylation of tyrosine residues, by the action 
of Lck, and/or by ZAP-70 auto-phosphorylation, is also important. Requirements for full 
catalytic activity include phosphorylation of the tyrosine residue Y493, located in the 
kinase domain of ZAP-70. Another important tyrosine residue is Y319, which is a 
positive regulator of ZAP-70 function (Wang et al., 2010). Overexpression of Y319F (a 
tyrosine residue mutated to phenylalanine) in ZAP-70 in Jurkat cells resulted in a 
dominant-negative effect, with reduced TCR-triggered activation of downstream 
signaling events (Di Bartolo et al., 1999). 
As there are molecules that lead to signaling that activate T cells there are also 
those that promote a down regulation of their functions. One such molecule is cytotoxic 
T-lymphocyte antigen-4 (CTLA-4). CTLA-4 has been implicated in termination of T 
cell activation as well as anergy induction and T regulatory cell function (Schneider et 
al., 2008; Walunas et al., 1994). There are many hypotheses on the manner in which 
CTLA-4 acts to dampen T cell responses. These include both intrinsic mechanisms 
causing alterations in cells that express the molecule as well as extrinsic mechanisms in 
which cells expressing CTLA-4 lead to decreased activity of other cells (Walker & 
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Sansom, 2011). The expression of CTLA-4 is constitutive in T regulatory cells whereas 
in conventional T cells the surface expression of CTLA-4 occurs following T cell 
activation. The function of CTLA-4 is controlled largely by regulation of its surface 
expression, as it is by its ligation on the cell surface that signaling is induced (Rudd et 
al., 2009).   
One intrinsic mechanism of CTLA-4 inhibition is competition with CD28 for 
ligand binding to CD80 and CD86 on APCs. CTLA-4 has both higher affinity and 
avidity for CD80 and CD86 thereby limiting the access of CD28 to these molecules. 
CTLA-4 inhibits T-cell activation by reducing IL-2 production and IL-2 receptor 
expression, and by arresting T cells at the G1 phase of the cell cycle (Krummel & 
Allison, 1996; Sansom, 2000). This occurs by several mechanisms that involve 
inhibition of transcription factors such as AP-1 (activator protein 1), NFκB (nuclear 
factor kappa-light-chain-enhancer of activated B cells) and NFAT (nuclear factor of 
activated T-cells). These are transcription factors central to lymphocyte activation that 
lead to diverse effector mechanisms such as proliferation and cytokine secretion 
(Murphy, 2012). CTLA-4 can also inhibit the formation of signaling platforms such as 
lipid rafts and microclusters in the T cell following TCR ligation. Specifically, 
microclusters that contain ZAP-70 induced that are formed following cell activation may 
be blocked following engagement of CTLA-4 (Rudd et al., 2009). An association 
between ZAP-70 and CTLA-4 has also been described by Guntermann and Alexander, 
(2002) demonstrating that ZAP-70 phosphorylation by Lck and proximal T cell receptor 
signaling can be impaired through the action of Src homology protein 2 domain-
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containing tyrosine phosphatase 1 (SHP-1) protein due its enhanced activity upon 
CTLA-4 ligation in T cells.  
Interestingly, Oosterwegel et al. (1999) demonstrated that CTLA-4 has a critical 
role in CD4+ T cell differentiation. T cells from CTLA-4 knockout mice carrying a class 
II restricted TCR specific for ovalbumin (ova) produced IL-4 even during primary 
stimulation and differentiated into almost pure populations of Th2 cells in contrast to 
wild type mice. In secondary stimulation with ova, CTLA-4 knockout mice expressed 
higher levels of IL-4 while the other group of mice expressed IFN-γ. Interestingly upon 
in vivo administration of anti-CD28 antibody, a Th2 differentiation was observed among 
CTLA-4 knockout mice, but not in wild-type mice. This study suggested that ligation of 
CTLA-4 blocks Th2 differentiation and that CD28 ligation alone may promote Th2 
differentiation of T cells. Also regarding CD4+ T cell phenotypes, Knieke et al. 2009 
demonstrated that CTLA-4 has a positive effect on Th1 cell migration. It was found that 
crosslinking of CTLA-4 together with CD3 and CD28 stimulation on activated Th1 cells 
increased expression of the chemokine receptors CCR5 and CCR7, which in turn 
enhanced cell migration. Interestingly Th1 lymphocytes expressing CTLA-4 increased 
their migration more than twice as compared to their negative counterparts showing that 
CTLA-4 can orchestrate specific migration of selected Th1 cells to sites of inflammation 
and antigenic challenge. 
The specific role of CTLA-4 in Treg function is still debated. Studies have 
shown that activation of Tregs leads to an increased expression of CTLA-4 and that the 
molecule is responsible for augmenting Treg function, as blockade of the molecule can 
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abolish the suppression capabilities of Treg cells. One extrinsic mechanism of CTLA-4 
is the secretion of TGF-β, a suppressive cytokine, by Treg cells upon their ligation on the 
cell surface (Walker & Sansom, 2011). Another described mechanism is the induction of 
indoleamine 2,3 dioxygenase (IDO) activity in APCs by Treg cells expressing CTLA-4. 
The induction of IDO leads to a localized tryptophan catabolism and causes its 
depletion. This leads other T cells to be inhibited from proliferating due to the lack of 
tryptophan (Fallarino et al., 2003). Interestingly there is also evidence that T cells 
expressing CTLA-4 can decrease the amount of CD80 and CD86 molecules on APCs by 
trans-endocytosis leading to impaired co-stimulation as well as suppression of T cell 
responses (Qureshi, 2011). 
 
Proteomics and antigens of MAP 
 Along with the need to better understand the immune response to MAP there is 
also a demand for research to study and evaluate proteins of MAP for use in diagnostic 
and vaccine applications. In spite of the existence of several diagnostic assays for 
paratuberculosis involving protein preparations of MAP, especially ELISA assays, there 
is still a great need to improve the sensitivity and specificity of these platforms 
(Facciuolo et al., 2013). The major way to do so is to use proteins that can be shown to 
be both specific and highly antigenic. Proteomic research in MAP is also important to 
better comprehend the molecular mechanisms that are involved in virulence and host 
pathogen interactions.     
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Proteomics is the study of all proteins produced by an organism or a defined 
fraction thereof. In the case of MAP, sequence analysis has revealed that the organism 
encodes over 4,300 proteins (Li et al, 2005), a very large amount to be analyzed. 
Another challenge in proteomic research for MAP is the genetic similarity it shares with 
other mycobacterial species. This similarity has been reported to be greater than 97% 
with Mycobacterium avium subsp. avium, making unique DNA segments and proteins to 
MAP rare (Bannantine et al. 2003). When analyzing the proteins of a cell or bacterium 
including MAP, it is important to study proteins in the different compartments of the 
bacterium to facilitate analysis and later functional assignment of proteins (Reisinger & 
Eichacker, 2007). 
 One important compartment of MAP is the envelope, which like that of all 
mycobacteria is composed of a cytoplasmic membrane, a periplasmic space and outer 
membrane. The layered architecture of the mycobacterial cell envelope is more related to 
that of Gram-negative bacteria, despite the fact that MAP and other mycobacteria are 
considered to be Gram-positive (Zuber et al., 2008). Fatty acids account for 30% to 40% 
of the cell envelope mass. Of these fatty acids, mycolic acids are responsible for forming 
the outer membrane of the envelope (Niederweis et al., 2010). Between the outer 
membrane and cytoplasmic membrane is the perisplasmic space which is composed 
mainly of an arabinogalactan and peptidoglycan polymer (Niederweis et al., 2010). The 
plasma membrane of mycobacteria does not appear to be different from that of other 
plasma biological membranes and has been reported to be homologous to those in other 
bacteria (Daffé & Draper, 1998). Also in the envelope are proteins that have both 
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physiologic roles such as porins for transporting of nutrients as well as roles involved in 
virulence such as fibronectin attachment proteins to facilitate infection of the host 
(Niederweis et al., 2010; Bannantine & Bermudez, 2013).  
Envelope proteins of MAP have been studied by He and De Buck, (2010). A 
total of 309 proteins were identified, along with 38 proteins that were determined to be 
surface exposed. Analysis of proteins was performed by separating proteins in SDS-
PAGE according to their molecular weight followed by in-gel digestion with trypsin 
resulting in a complex peptide mixture, which was then analyzed directly by mass 
spectrometry. To analyze surface exposed proteins, an enzymatic shaving technique was 
performed with trypsin on bacterial cells. Interestingly, very low correlation was 
observed between proteins found to be part of the cell envelope in comparison to those 
determined to be surface exposed. The authors suggest that this is likely due to the loose 
association of these proteins with the cell wall, making them less stable and more prone 
to detachment. As has been described, several surface proteins can be attached to the cell 
wall of bacteria in a non-covalent way and have been reported to be lost during mild 
standard manipulations (Kocincova et al., 2004). The study also identified one PPE 
protein in the cell wall fraction and four PPE proteins in the cell surfaced exposed 
proteome (He & De Buck, 2010). Yet protein interactions and potential antigenicity of 
proteins were not addressed in this study. 
 A technique that has been used to analyze proteins present in membranes as well 
as their interactions is blue native PAGE (polyacrylamide gel electrophoresis). This 
technique was originally described by Schagger and Jagow (1991) to study protein 
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complexes in mitochondria. Blue native PAGE is a technique that uses non-ionic 
detergents to solubilize hydrophobic proteins, often associated with membranes, yet 
allow protein interactions to remain intact and maintain proteins in their native state 
(Reisinger & Eichacker, 2007). Coomassie blue G-250 is added to solubilized proteins to 
give them a negative charge to allow for their migration in blue native-PAGE. The 
technique allows for the characterization of protein complexes within membrane 
fractions. To visualize subunits of complexes, it is necessary to breakdown inter-protein 
interactions. This can be done with the use of anionic detergents such as SDS (sodium 
dodecyl sulfate) which denatures proteins while giving them a negative charge 
(Reisinger & Eichacker, 2008). After treatment of complexes with SDS samples can be 
run on a polyacrylamide gel to visualize the subunits of each complex. After separation 
of proteins, mass spectrometry can be performed to identify individual proteins 
(Reisinger & Eichacker, 2007). 
 Blue native PAGE has been performed to analyze proteins present in membranes 
of bacterial pathogens. In Borrelia burgdorferi, 10 complexes were found within the 
outer membrane along with the subsequent finding that an adhesion protein involved in 
infection was part of one complex (Yang et al., 2011). Most complexes and protein 
interactions found were of unknown function, and interestingly many contained the same 
proteins as subunits. These identified protein subunits which were found in more than 
one complex are likely abundant and may have important roles within the membrane 
(Yang et al., 2011). A major discovery was made in Helicobacter pylori using blue 
native PAGE. The CagA (cytotoxin-associated gene A) protein is a major virulence 
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factor involved in the induction of gastric adenocarcinoma by the bacterium, and was 
found to be part of a complex with DNA gyrase subunit A (GyrA) protein  (Hatakeyama 
& Higashi, 2005; Pyndiah et al., 2007). This led to the conclusion that the interaction of 
these two proteins is likely responsible for the higher growth rate of pathogenic isolates. 
This is due to the interaction of CagA with GyrA which likely facilitates normal DNA 
replication and leads to a better development of the bacterial cell (Pyndiah et al., 2007). 
Zheng et al. (2011) investigated complexes present within the envelope of M. bovis 
bacillus Calmette-Guérin (BCG). The study provided information in regards to bacterial 
physiology, finding several complexes and protein interactions involved in bacterial 
metabolism such as the Emb (Ethambutol) protein complex that is involved in synthesis 
of lipoarabinomannan and other cell envelope components (Alderwick et al., 2006; 
Zheng et al., 2011) . 
The envelope of MAP needs to be further characterized for a better 
comprehension of its physiology and related virulence, as well as for the identification of 
potential antigens for diagnostic and vaccine development. Proteins associated with the 
cell envelope of MAP are likely to be the first to interact with the host and, therefore, the 
first proteins for immune recognition (Kleinnijenhuis et al., 2011). Identifying proteins 
present in the envelope, especially their interactions, would aid in comprehending the 
pathogenesis of MAP infection. Several proteins with roles in virulence have been found 
to be associated with the envelope of mycobacteria, including proteins of the PPE 
(proline-proline-glutamic acid) family as well as those of the antigen 85 complex 
(Forrellad et al., 2013). Both of these families of proteins have roles in virulence, and 
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proteins of the antigen 85 complex have been demonstrated to be highly immunogenic 
(Kathaperumal et al., 2008; Deng & Xie, 2012). Therefore, characterization of proteins 
and protein interactions present in the envelope become critical not only to the 
comprehension of the physiology and pathogenesis of the organism but also to identify 
potential antigenic proteins for use in vaccines and diagnostic assays. 
Proteomic studies have also investigated other important factors that need to be 
considered in MAP research. Radosevich et al. (2006) studied the potential differences 
that may occur between different MAP isolates and changes that occur with laboratory 
adaptation of MAP strains. The proteomes of two isolates of MAP, a laboratory-adapted 
strain K-10 and a low passage clinical isolate were investigated. Proteins were extracted 
from both the envelope as well as the cytosol. The last step consisted of 
ultracentrifugation, resulting in a supernatant corresponding to the cytosolic protein 
fraction and a pellet corresponding to the bacterial envelope. Interestingly, there was 
87% similarity between both strains analyzed over the 874 total proteins found. This 
study also described specific proteins that were up or down regulated in each strain in 
the envelope or cytosolic compartments. One of these proteins was MAP4336 which was 
upregulated 4.7-fold in the membrane fraction of isolate 187. This is an integral 
membrane protein from the MVIN family of proteins that have been found to be 
virulence factors. This study demonstrated that different low- and high-passage strains of 
MAP do have differences within their proteomes, and this must be considered when 
searching for virulence factors and antigens. 
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In an attempt to better understand the responses of MAP when infecting the host 
or when present in the environment, Gumber et al. (2009) analyzed the proteome of 
MAP under the stress of hypoxia and nutrient deprivation. After treating cultures with 
media containing either less oxygen or fewer nutrients, protein extraction was 
performed. This consisted of collecting bacterial cells and treating them with a lysis 
buffer containing urea, followed by centrifugation to remove cellular debris. Proteins 
were then run on two dimensional SDS-PAGE gels. The greatest number of 
differentially expressed proteins was categorized as hypothetical proteins with no 
functions found, however, some proteins were associated with the response of MAP to 
these stress conditions. Hypoxia induced the expression of heparin-binding 
haemagglutinin adhesion (HBHA)-like protein, which is required for extra pulmonary 
dissemination of M. tuberculosis (Pethe et al., 2001). The role of HBHA in MAP is not 
known, but is likely induced in vivo during infection, as revealed by this study.  
To make use of proteins described as being differentially regulated during stress 
conditions, Gurung et al. (2012) analyzed differentially regulated proteins using bio-
informatics software to predict both T cell and B cell epitopes within proteins. This 
analysis generated a list of 25 candidates, 8 of which were identified as potential 
candidates for study of antibody- and cell-mediated immune responses within infected 
hosts. The same research group evaluated the humoral response to these proteins in 
sheep (Kawaji et al., 2012). A recombinant antigen preparation was made and used in an 
ELISA platform to evaluate the responses among sheep with a wide range of disease 
states. The ELISA developed had similar sensitivity to a commercial ELISA and some 
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serum samples from uninfected sheep were also reactive. This demonstrates that finding 
improved antigens is not easy. There is still a need to find better antigens or antigen 
preparations that reliably distinguish infected animals from healthy on diagnostic tests. 
 
Antigen preparations of MAP used in diagnostic applications 
Several protein preparations of MAP have been used in different assay platforms 
to diagnose infection. A culture filtrate preparation, also known as johnin purified 
protein derivative (jPPD), has been used for cell-mediated immune tests, specifically the 
interferon-gamma release assay (Stabel & Whitlock, 2001). This is an antigen 
preparation made by filtering the culture of MAP after removal of bacterial cells. A 
problem with this preparation is the lack of standardized protocols for their production. 
Wynne et al. (2012) investigated differences in jPPDs and found that although broad 
proteomic composition of different jPPD preparations was similar, there were 
considerable differences in absolute abundance of specific proteins. These differences 
were attributed mainly to strain diversity as well as age of culture prior to antigen 
preparation. 
 Another antigen preparation that is widely used is the protoplasmic antigen 
(PPA). This preparation was described for mycobacteria by Beam et al. (1969) and early 
on demonstrated high reactivity and specificity when used to differentiate mycobacterial 
infections. This preparation consists of physical disruption of the bacterial culture 
followed by removal of bacterial debris and cell wall components (Beam et al., 1969). In 
MAP this preparation was used by Yokomizo et al. (1983) to develop an ELISA 
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platform for diagnosis of paratuberculosis. This assay identified 58% of cattle with 
positive fecal cultures. A problem with false positive results was resolved by the same 
author in 1985 by pre-absorption of sera with Mycobacterium phlei to remove cross-
reactive antibodies (Yokomizo et al., 1985). Both the PPA preparation was well as the 
pre-absorption steps are used in commercial ELISAs today. 
 An improvement to ELISA sensitivity and specificity was achieved by using an 
ethanol extract preparation to isolate antigens of MAP (Eda et al., 2006). This assay was 
termed Ethanol Vortex ELISA (EVELISA) because the antigen preparation involved 
treating bacterial cells with 80% ethanol followed by agitation. The addition of a pre-
absorption step to this assay resulted in a more robust and sensitive measure of MAP-
specific antibodies (Scott et al., 2010). The estimated sensitivity of this assay also 
increased to 97.1% with a specificity of 100%. Because this preparation gently extracts 
the surface components of MAP, and these components appear to be useful antigens, we 
sought to further examine the envelope of MAP. 
 
Studies to identify proteins relevant for diagnostic and vaccine development  
Research has also focused on identifying specific proteins that could be used to 
diagnose MAP. One method that provides a platform to analyze as well as directly 
compare several proteins at once is the protein array (Bannantine et al., 2008). Upon 
analysis of 92 MAP proteins, Bannantine et al. (2008b) demonstrated the diagnostic 
potential of some proteins as these could detect antibodies in serum of animals soon after 
experimental infection. The protein encoded by MAP1087, a putative protein on the 
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surface of MAP, showed the highest antibody reactivity throughout the course of the 
study and antibodies to this protein were observed within 70 days after experimental 
infection.  
More recently, Facciuolo et al. (2013), screened a culture filtrate preparation of 
MAP for reactivity among infected animals. Of the 162 total proteins identified, 4 
proved to be antigenic by reacting to sera of subclinical and clinical animals. Nagata et 
al. (2013) discovered a very promising antigen, an enoyl coenzyme A hydratase encoded 
by MAP1197. In the ELISA format, this protein demonstrated the capacity to detect 
antibodies in subclinical animals 2–7 months earlier than by a commercially available 
ELISA kit. They also reported a 96.7% sensitivity and specificity of the ELISA. 
Fewer studies have addressed the use of antigens in the IFN-γ release assay to 
detect cell-mediated immune responses. The advantages of this assay are that it could 
potentially have a greater sensitivity to diagnose subclinical animals, as it measures Th1 
type responses which are characteristic of early stage infection. Hughes et al. (2013) 
investigated the potential of 30 proteins, previously identified as potentially MAP-
specific in an IFN-γ release assay to diagnose subclinical infection in sheep. Of the 
candidates studied, all 30 recombinant proteins elicited an IFN-γ response in at least one 
of nine animals. Four proteins, encoded by MAP1297, MAP1365, MAP3651c and 
MAP0268c, were selected for further investigation based on the higher number of 
reactive animals as well as the magnitude of the response. Of these proteins, MAP3651c 
was the only one that demonstrated an increased response in infected animals in 
comparison to non-infected animals. Mikkelsen et al. (2011) investigated 14 
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recombinant proteins and compared them to jPPD in an IFN-γ release assay to detect 
paratuberculosis in cattle.  jPPD proved to be unspecific while some proteins had the 
potential to differentiate among infected and non-infected animals. These included the 
hypothetical proteins LATP-2, MAP-1 and MAP-2 which do not share homology with 
any proteins from Mycobacterium avium subsp. avium. However it is still unknown 
whether these proteins are actually expressed by MAP, thus studies that investigate 
proteins that have been shown to be expressed by the bacterium are at an advantage for 
finding antigenic proteins.       
Some recombinant proteins have also been evaluated as vaccine candidates. The 
current paratuberculosis vaccine available in the US (Mycopar, Boehringer Ingelheim) is 
a heat-killed whole cell antigen that has several disadvantages. These include: a potential 
health hazard to the veterinarian who administers the vaccine, granuloma formation at 
the injection site and possible interference with bovine tuberculosis skin testing as well 
as serologic detection of MAP infected animals (Patton, 2011). With this in mind the use 
of subunit vaccines may prove the most efficacious in developing a vaccine for 
paratuberculosis to reduce or eliminate these problems while maintaining the beneficial 
properties of the vaccine (Stabel et al., 2012). Koets et al. (2006), studied the use of a 
recombinant MAP protein, Hsp70, as a subunit vaccine in cattle experimentally infected 
with MAP. The results of the study demonstrated that recombinant MAP Hsp70 
significantly reduced shedding of bacteria in feces during the first 2 years following 
experimental infection, demonstrating its potential as a vaccine candidate.  
Kathaperumal et al. (2008), studied three recombinant proteins of the antigen 85 
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complex as well as superoxide dismutase for their ability to protect calves after 
experimental challenge with MAP. Results from this study indicated that all four 
recombinant proteins induced a good Th1 response and conferred some protection 
against MAP infection in calves. Stabel et al. (2012) studied protein cocktails for their 
ability to protect mice to infection with MAP. The most promising cocktail contained the 
proteins MAP1087, MAP1204, MAP1272c; two of which had previously been shown to 
be antigenic in protein arrays blotted against sera from experimentally infected calves 
(Bannantine et al., 2008b). This cocktail of proteins elicited high IFN-γ responses as 
well as a reduction in MAP colonization of the liver, spleen, ileum and mesenteric 
lymph node of mice. Even with several attempts to improve and develop novel vaccines 
for paratuberculosis none have yielded an efficacious alternative. With this there is the 
need for new approaches such as the analysis of envelope protein complexes to identify 
novel promising antigens for vaccine development.  
 In conclusion, there have been several studies that have shed light in to MAP and 
mechanisms used by the bacterium to cause disease, however there is still a great need 
for a better understanding of Johne’s disease and the development of improved control 
strategies. The research presented in this thesis investigated how T cells change in 
relation to infection status, by studying the signaling molecules ZAP-70 and CTLA-4, to 
investigate alterations among this cell population which is crucial for the control of 
paratuberculosis. Secondly, protein complexes in the envelope MAP were investigated 
to gain insight in to the physiology and pathogenesis of the organism as well as to 
identify novel antigens for diagnostic and vaccine development.  
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Abstract 
Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 
Johne’s disease, a chronic enteric disease of ruminant animals. In the present study, blue 
native PAGE electrophoresis and 2D SDS-PAGE were used to separate MAP envelope 
protein complexes, followed by mass spectrometry (MS) to identify individual proteins 
within the complexes. Identity of individual proteins within complexes was further 
confirmed by MS upon excision of spots from 2D SDS-PAGE gels. Among the seven 
putative membrane complexes observed, major membrane protein (MAP2121c), a key 
MAP antigen involved in invasion of epithelial cells, was found to form a complex with 
cysteine desulfurase (MAP2120c). Other complexes found included those involved in 
energy metabolism (succinate dehydrogenase complex) as well as a complex formed by 
Cfp29, a characterized T cell antigen of M. tuberculosis. To determine antigenicity of 
proteins, Western blot was performed on replicate 2D SDS-PAGE gels with sera from 
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noninfected control cows (n=9) and naturally infected cows in the subclinical (n = 10) 
and clinical (n=13) stages of infection. Clinical animals recognized MAP2121c in 
greater proportion than subclinical and control cows, whereas cysteine desulfurase 
recognition was not differentiated by infection status. To further characterize 
antigenicity, recombinant proteins were expressed for 10 of the proteins identified and 
evaluated in an interferon-gamma (IFN- γ) release assay as well as immuno-blots. This 
study reveals the presence of protein complexes in the cell envelope of MAP, suggesting 
protein interactions in the envelope of this pathogen. Furthermore the identification of 
antigenic proteins with potential as diagnostic targets were characterized.  
 
Introduction 
Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of 
paratuberculosis (Johne’s disease), a chronic enteric wasting disease of ruminant animals 
with worldwide distribution (1). Paratuberculosis is predominantly a subclinical disease 
with economic impact mostly in dairy cattle in the US. As the disease progresses, there 
is a loss in milk production, as well as higher incidence of mastitis and infertility, 
leading to early culling of animals (2). Currently, the diagnostics of MAP is based 
mainly on the detection of the bacterium in feces by culture or PCR and by ELISA 
detection of MAP-specific antibodies.  However, crude antigen preparations are used for 
antibody detection and these can limit the detection of asymptomatic animals. Detection 
of animals in the subclinical stage of infection can be difficult as these animals typically 
excrete MAP in low numbers and have not yet developed measurable antibody titers to 
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MAP (3,4). With this in mind, research to identify antigens that can be used to 
sensitively diagnose the disease is needed; in particular, antigens that are conducive for 
use in the IFN-γ assay, a measure of Th1-mediated immune response elicited by animals 
in the subclinical stage of infection (5).  
MAP is a member of the avium complex of mycobacteria and has an envelope 
comprised of a cytoplasmic membrane and a cell wall consisting of peptidoglycan, 
arabinogalactan, mycolic acids and proteins (6,7). Proteins associated with the cell 
envelope of MAP are likely to be the first to interact with the host and, therefore, the 
first proteins for immune recognition (8). Several antigenic proteins as well as those with 
roles in virulence have been found to be associated with the envelope of mycobacteria, 
including proteins of the PPE family (9). Thus, characterization of proteins present in the 
envelope is critical not only to the comprehension of the physiology and pathogenesis of 
the organism but also to identify potential antigenic proteins for use in vaccines and 
diagnostic assays. 
In the present study, blue native (BN) PAGE and 2D SDS-PAGE were used to 
characterize protein complexes in the envelope of MAP. BN PAGE is a technique that 
allows for the isolation of protein complexes with the use of non-ionic detergents 
allowing the solubilization of hydrophobic proteins which can be missed with other 
techniques such as iso-electric focusing (10). Mass spectrometry was performed on blue 
native gels as well as 2D SDS-PAGE gels to identify proteins within complexes. To 
determine antigenicity of proteins, Western blot was performed on replicate 2D SDS-
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PAGE gels with sera from noninfected and naturally infected animals to identify novel 
antigens with potential as vaccine and diagnostic targets. 
Materials and Methods 
Bacteria. 
A low passage clinical isolate of MAP, strain 509, was isolated from the jejunum 
of a cow manifesting clinical signs of paratuberculosis and was confirmed as MAP by 
IS900 and ISMAP02 PCR (data not shown). The bacterium was grown to log phase 
(Abs540nm = 0.2-0.4) in Middlebrook 7H9 broth (pH 5.9) (Becton Dickinson) containing 
0.05% Tween 80 (Sigma) and ferric mycobactin J (2 mg/liter; Allied Monitor), 
supplemented with oleic acid, albumin, dextrose, and catalase enrichment (OADC, BD). 
Cultures were pelleted by centrifugation at 10,000 x g for 30 min at 4°C and washed 
twice with phosphate buffered saline (PBS). After the last centrifugation, pellets were 
stored at -80°C until used for envelope extraction.  
Bacteria cell wall/membrane preparation.  
  Cell wall/membrane preparation was performed as described in Radosevich et al. 
(11) with some modifications. Sonication was performed in a hypotonic buffer (10 mM 
HEPES sodium salt, 1 mM EGTA, pH: 7,5, containing 1:100 protease inhibitor cocktail, 
Sigma). The sample was adjusted to 250 mM sucrose and centrifuged at 10,000 x g for 
30 min to remove unbroken cells and cellular debris. The supernatant was collected and 
centrifuged at 150,000 x g for 1 h to isolate the cell wall/membrane. Protein 
quantification was performed using the Bio-Rad protein assay (Bio-Rad Laboratories) 
and all samples were stored at -20°C until use. 
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Blue Native PAGE.   
Separation of the protein complexes present in the cell wall/membrane of MAP 
was performed by blue native PAGE (12). Samples were solubilized by adding 100 µg 
of protein to Native-PAGE sample buffer (Life technologies) with 0.5% digitonin (Life 
Technologies) for 1 h at 4°C in a rotating shaker. To remove insoluble protein, samples 
were centrifuged for 30 min at 14,000 x g at 4°C. The resulting supernatant was 
combined with G-250 coomassie in a final concentration corresponding to 25% of the 
detergent concentration. Extracts were loaded onto a 3-12% Native-PAGE gel (Life 
technologies). Electrophoresis was performed in Native-PAGE anode buffer (Life 
technologies,) and a cathode buffer containing 0.02% G-250 at 150 V. When the dye 
front migrated halfway into the gel the cathode buffer was replaced with cathode buffer 
containing 0.002% G-250 for the remainder of the 3hr run.  
2D SDS-PAGE.   
Second dimension SDS-PAGE was performed as described by Schamel, 2008 
(13), with some modifications. Gel strips were excised from the blue native gel and 
stored at -20°C until use. To denature protein complexes the gel strips were incubated  in 
a solution of 2x SDS sample buffer and 2x NuPAGE sample reducing agent (Life 
technologies) for 30 min at room temperature (RT) and incubated at 70°C for another 30 
min. The strips were allowed to cool to RT for 30 min. Each strip was then inserted into 
a single well 1.0 mm 4-12% bis-tris gel (Life technologies). The strip was covered with 
1x SDS sample buffer and 1 x NuPAGE sample reducing agent. Electrophoresis was 
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performed for 50 min at 200 V in MOPS buffer. Gels were stained using the SilverQuest 
silver stain kit (Life technologies). 
Western-blot of 2D SDS-PAGE gels. 
Electrophoretic transfer of proteins onto nitrocellulose was performed with a 
Trans Blot Cell (Bio-Rad Laboratories) with sodium phosphate buffer (25 mM) at 0.9 A 
for 90 min. After transfer, the membranes were blocked with PBS containing 0.1% 
Tween 20 (PBST) plus 2% bovine serum albumin (BSA) overnight at 4°C. Serum 
samples were diluted 1:200 in PBST with 2% BSA and incubated for two hours at RT. 
After the incubation, three washes were performed with PBST for 10 min each. 
Secondary antibody used was anti-goat IgG Horse radish peroxidase conjugate (Vector 
Labs) at a dilution of 1:20,000 for one hour of incubation. Following another three 
washes as described above, blots were incubated with SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Fisher) for protein detection and exposed to X-ray 
film.   
Preparation of trypsin digests.  
2D-SDS-PAGE and native PAGE gels stained with the SilverQuest silver stain 
kit were imaged using the Gel Doc EZ imaging system (Bio-Rad Laboratories). 
Identified spots (2D SDS-PAGE gels) or bands (native page gels) were excised from the 
gels and placed in siliconized tubes containing destaining buffer (solution of 30% 
acetonitrile (ACN) and 70% triethylammonium bicarbonate (TEABB) and incubated at 
RT for 10 min. Destaining buffer was removed and this step was repeated 3 times. The 
gel pieces were then dried in a vacuum centrifuge without heat. Next the gel pieces were 
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rehydrated with a solution of 10 mM TCEP (Tris (2-carboxyethyl)-phosphine) for 5 min 
at 4°C then incubated in a 56°C water bath for 1 h. Alkylation was performed with a 
solution of 55 mM iodoacetamide for 1h at RT. Following incubation, the alkylation 
buffer was replaced with destaining buffer. For trypsin digestion, gel pieces were 
rehydrated with TEABB for 20 min at 4°C, followed by another incubation at 90°C for 
20 min to heat denature proteins. After samples cooled to RT, one wash was performed 
with destaining buffer and the samples were dried in a vacuum centrifuge. A solution of 
proteomics grade trypsin (20 µg/ml; Sigma Aldrich) diluted in TEABB was added to 
cover the gel pieces and samples were incubated for 5 min at 4°C A solution of 60% 
TEABB/40% ACN containing 25 µg/ml trypsin was used to cover the gel pieces and 
incubated overnight at 37°C in a shaking water bath. The next day the samples were 
cooled to RT. The digest solution was transferred to clean siliconized tubes. The gel 
slices were extracted 2x with 50:50 (vol/vol) ACN:5% formic acid, 1 x with 15:50:35 
(vol/vol) isopropanol:ACN:5 % formic acid, and 2x with 80% ACN. All extracts were 
combined with the digest solution and dried in a vacuum centrifuge. The samples were 
stored dry at –20°C until used. 
On line peptide chromatography and mass spectroscopy. 
Samples were separated  on a Proxeon Easy-nLC (Thermo Fisher Scientific), 
C18, 3 um, 75 μm × 100 mm column in mobile phase A (95% H2O: 5% acetonitrile and 
0.1% formic acid) and mobile phase B (5% H2O:95% acetonitrile and 0.1% formic acid) 
gradient, 0% B for 9 min, 6%–15% B from 10–80 min, 15–30% B from 80–88 min, 30–
90% B from 88–90 min, at 300 nl/min. The analytical column was connected to a 
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Proxeon Nanospray Flex Ion Source (Thermo Fisher Scientific) on the front end of a 
LTQ OrbiTrap Velos (Thermo Fisher Scientific) mass spectrophotometer. The capillary 
temperature was set at 275°C and spray voltage optimized using the API stability 
evaluation software for the LTQ OrbiTrap Velos. Data dependent method settings were 
as follows: FTMS was 60,000 resolution from 300–2000 m/z followed by up to 10 ion 
trap MSMS scans. Activation was CID using normalized collision energy of 35. 
Minimal signal required was 5000 and repeat mass exclusion duration of 60 s (14). 
Database Searches.   
Tandem mass spectra were extracted by Protein Discoverer version 1.3.0.339. 
Charge state deconvolution and deisotoping were not performed. All MS/MS samples 
were analyzed Sequest (Thermo Fisher Scientific; version 1.3.0.339) and X! Tandem 
(The GPM, thegpm.org; version CYCLONE (2010.12.01.1) X! Tandem was set up to 
search the SP-MAP1770_120619.fasta (7368 entries) assuming trypsin cleavage. 
Sequest was set up to search SP-MAP1770_120619.fasta (7368 entries) also assuming 
trypsin cleavage. Sequest and X! Tandem were searched with a fragment ion mass 
tolerance of 0.08 Da and a parent ion tolerance of 10.0 PPM. Iodoacetamide derivative 
of cysteine were specified in Sequest and X! Tandem as fixed modifications. Oxidation 
of methionine was specified in Sequest and X! Tandem as a variable modification. 
Peptide and protein false discovery rates were 0.1% and 0.1% respectively with Scaffold 
probabilities set at 99% for protein and 95% for peptide identification. 
Criteria for Protein Identification. 
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  Scaffold (version Scaffold_3.6.5, Proteome Software Inc.) was used to validate 
MS/MS based peptide and protein identifications. Peptide identifications were accepted 
if they could be established at greater than 95.0% probability as specified by the Peptide 
Prophet algorithm (15). Protein identifications were accepted if they could be established 
at greater than 99.0% probability and contained at least 2 identified peptides. Protein 
probabilities were assigned by the Protein Prophet algorithm (16). Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis 
alone were grouped to satisfy the principles of parsimony. 
Bioinformatic analysis.  
 Predictions of trans-membrane topology were conducted using the TMHMM 2.0 
program, publicly available from the Centre for Biological Sequence Analysis at the 
Technical University of Denmark http://www.cbs.dtu.dk/services/TMHMM/. Functional 
association prediction between identified proteins was analyzed using STRING version 
9.05 interaction database http://string-db.org/. 
Cloning of Mycobacterium avium subsp. paratuberculosis coding sequences. 
Proteins that were identified by MS from 2D SDS PAGE gels and demonstrated 
antigenicity on Western blot analyses were cloned and expressed following protocols 
previously described (17). The pMAL protein fusion and purification system was used 
with the pMAL-c2x expression vector (New England Biolabs). After identification of 
the proteins of interest, the corresponding coding sequences were amplified from the 
annotated MAP genome (18). Primers were designed for the n-terminal and c-terminal 
portions of the proteins to span their whole coding sequence, XbaI and HindIII 
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restriction sites were added to the 5’ and 3’ primers respectively to allow digestion and 
insertion into the expression vector. The protein cysteine desulfurase (MAP2120c) had 
to be cloned in two fragments because its size was too large (2,013 kb) for full-length 
amplification and cloning. Amplification of the desired DNA sequences for insertion 
into the expression vector was performed using a master mix containing 20 µl GC Melt 
Buffer 2x Advantage (Clontech), 1 µl each of forward and reverse primers, 1 µl K-10 
genome template, 0.2 µl polymerase, 20 µl distilled water and 2 µl dNTP nucleotide mix 
(Roche). PCR products were purified using the Gene Clean Turbo kit (Q-Biogene) and 
digested for one h at 37°C with XbaI and Hind III enzymes (New England Biolabs). 
Following purification with the Gene Clean Turbo kit, ligation was performed overnight 
at 16°C with T4 ligase and T4 ligase buffer (New England Biolabs). E. coli DH5-α was 
transformed by heat shock and incubated overnight in LB agar containing carbenicillin. 
To confirm transformation and ligation, 8 colonies from each agar plate were screened 
for the protein coding sequence of interest by PCR. One colony from each plate 
confirmed by PCR to have the cloned plasmid was further amplified by overnight culture 
in LB broth containing glucose (0.2%) and carbenicillin (100 mg/ml). Sequencing of 
cloned plasmids was performed to confirm in-frame insertion of the coding sequence to 
the 3′ end of the malE gene in the vector, which encodes maltose binding protein (MBP) 
allowing for protein purification by affinity chromatography. 
Protein expression and purification.  
Protein expression and purification followed protocols previously described 
(17,19). Using the pMAL protein fusion and purification system (New England 
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Biolabs,), overnight cultures of cloned E. coli DH5-α were inoculated into 2 liter flasks 
containing 1 liter of LB broth supplemented with glucose (0.2%) and carbenicillin (100 
µg/ml) and cultured in a rotary shaker at 37°C. When an OD600nm of 0.4-0.6 was reached, 
cells were induced with 360 µl of 1M isopropyl-1-thio-β-D-galactoside (IPTG) solution 
for 2 h. After induction, cells were pelleted by centrifugation and resuspended in column 
buffer (20 mM TrisCl, 1 mM EDTA, pH: 7.4) and stored overnight at -20°C. Upon 
thawing of cells, sonication was performed for 4 min in an ice bath and the lysate was 
clarified by centrifugation. For purification of the fusion protein, affinity 
chromatography was performed using an amylose resin column. Protein was eluted with 
column buffer containing 10 mM maltose. Eluted protein was dialyzed in 1 liter PBS at 
4°C with three exchanges using 10K Molecular weight cut off dialysis cassettes (Thermo 
Fisher). Final purified proteins were analyzed by SDS–PAGE gels stained with GelCode 
Blue (Thermo Fisher), and quantified by the Bio-Rad protein assay (Bio-Rad 
Laboratories) for use on immuno blots and interferon-gamma release assay. 
Immunoblots.   
For immunoblots, 12% SDS-polyacrylamide gels were cast with two lanes, one 
long lane across the top of the gel and another for loading protein size standard. A 100 µl 
aliquot of recombinant protein (4.5 µg total) was loaded to the long lane and the gel 
submitted to electrophoresis. The subsequent steps used for transfer to nitrocellulose are 
essentially those of the Western blot on 2D SDS-PAGE described above.  The 
nitrocellulose blot was placed into a slot-blot device (Bio-Rad Laboratories) and 
individual serum samples were loaded into independent slots on the device. After 2 h, 
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the slots were washed in PBS-T, the device was disassembled and the nitrocellulose blot 
was placed in a tray containing PBS-T for additional washes. Blots were incubated with 
secondary antibody for 90 min and after washing with PBS-T were incubated with 
SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher) for protein 
detection and exposed to X-ray film. Band intensities were measured using ImageJ 
software by the National Institutes of Health http://rsbweb.nih.gov/ij/. In the case of a 
recombinant protein demonstrating more than one band of similar molecular weight, 
both were considered when calculating in band intensities. 
Interferon-gamma release assay.   
Whole heparinized blood was added in 300 µl volume to each well of a 96-well 
plate to evaluate the IFN-γ response to each recombinant protein. In addition, a whole-
cell sonicate preparation and an envelope fraction of MAP were also added for 
comparison of protein reactivity in the assay and as controls to assess animal infection 
status. Concanavalin A (ConA; Sigma) and pokeweed mitogen (PWM; Sigma) were 
used as positive controls to validate cell reactivity. Each protein was tested in the 
concentrations of 10, 5 and 2.5 µg/ml and incubated for 18 h at 39°C in a humidified 
atmosphere with 5% CO2. After incubation, plates were centrifuged for 5 min at 2500 x 
g and plasma samples were harvested to measure secreted IFN-γ. The Bovigam® 
(Prionics) ELISA assay was used to measure IFN-γ levels in antigen-stimulated plasma. 
Statistical Analysis 
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 Data analysis was performed using SAS 9.3 (SAS Institute Inc.). To analyze 2D 
western-blot data, Fisher’s exact test was used. IFN-γ and slot blot results were analyzed 
with a one way ANOVA and linear combinations of means.  
Results: 
Protein Complexes found by Blue Native PAGE.  
In this study, a total of seven putative protein complexes were observed in blue 
native PAGE gels, ranging from molecular weights of 119 to 996 kDa (Figure 1). 
Complexes I, II and V were most readily observed following Coomassie staining (Figure 
1).  To achieve these results, the detergents digitonin, Triton X-100 and n-dodecyl-β-d-
maltoside (DDM) were compared as solubilizing agents at different concentrations. 
Digitonin at 0.5% was chosen as this was the lowest concentration where all complexes 
could be defined in blue native gels (data not shown) and because of its superior 
properties to disrupt annular lipids, which surround protein complexes (20). To identify 
the proteins present within each complex, complexes were denatured and run on 2D 
SDS-PAGE gels, but low resolution of proteins in 2D SDS-PAGE gels necessitated 
further optimization. Optimal results were obtained after samples were dialyzed and 
treated with benzonase to remove nucleic acids prior to running BN gels for subsequent 
2D SDS-PAGE (data not shown). Several protocols were attempted to perform 2D SDS-
PAGE, with the best protocol being a modification of that published by Schamel (13), 
requiring pre-incubation of samples in a 70°C water bath. Identification of proteins 
within complexes was performed by MS of excised bands from blue native gels (Figure 
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1, Table 1) and spots observed on 2D SDS-PAGE gels (Figure 2). A total of 29 spots 
were observed on 2D SDS-PAGE gels, 13 of which could identified by MS (Table 2). 
A summary of proteins found in each putative complex can be found in Table 1. 
Complex I was comprised of a cysteine desulfurase (MAP2120c) and major membrane 
protein (MAP2121c). This was confirmed by MS analysis of the representative band on 
the blue native gel (Table 1) as well as spots corresponding to the proteins found on the 
2D SDS-PAGE gel (Figure 2, Table 2). Complex II was comprised of several proteins. 
Cfp29 (MAP0630c) was found in this complex along with a Dyp-type peroxidase family 
protein (MAP0631c). Other proteins found in complex 2 are involved in protein 
transport such as members of the Sec pathway (Sec D, Sec F) and members of the ABC 
transport system. 
 Members of the succinate dehydrogenase complex were found in complex III. 
Here the flavoprotein and iron-sulfur protein subunits of the complex, encoded by 
MAP3698c and MAP3967c respectively, were found. In complex VI, the protein 
glutamine synthetase (MAP1962) was observed to form a complex. Finally, complex VII 
was comprised of proteins involved in fatty acid synthesis, FadA2 (MAP3693), FadD15 
(MAP1925) and FabG4 (MAP3692c).  
Interactions of proteins within complexes were predicted by String 9.05 analyses. 
Among them were major membrane protein (MAP2121c) and cysteine desulfurase 
(MAP2120c) found in complex I (Figure 3). Others included Cfp29 (MAP0630c) and a 
dyp-type peroxidase family protein (MAP0631c) found in complex II and the proteins in 
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complex VII, FadA2 (MAP3693), FadD15 (MAP1925) and FabG4 (MAP3692c) (Figure 
3).  
Antigenicity of membrane complex proteins by 2D Western blot.   
 To identify antigenic proteins present within the envelope compartment of MAP, 
Western blots were performed using sera from 13 clinical, 9 subclinical and 10 control 
noninfected animals. Figure 4 contains immune blots representative of each infection 
stage of Johne’s disease and serum reactivity for each protein is summarized in Table 3. 
Cysteine desulfurase (MAP2120c) garnered the most reactivity amongst all animals, 
reacting with sera from all clinical and control animals as well as 77.8% of subclinical 
animals. Several other proteins demonstrated antigenicity dependent upon the animal’s 
stage of infection. Major membrane protein (MAP2121c) was recognized by 61.5% of 
animals with clinical paratuberculosis as opposed to 10% of control animals (p <0.05) 
and 22.2% of subclinical animals. Interestingly, linocin/cfp29 (MAP0630c) had an 
opposite pattern of reactivity with 40% of control animals demonstrating antibodies to 
the protein in comparison to 7.6% of animals in the clinical stage of disease. 
Bacterioferritin (MAP1595c) was also found to be a strong, but not specific antigen 
showing reactivity in 92.3% of clinical, 55.6% of subclinical and 60% of control 
animals. 
Cell mediated immune response to selected protein complex subunits. 
Further evaluation of recombinant proteins in an IFN-γ assay demonstrated 
potential to discriminate animals in the early stage of infection. Most proteins 
demonstrated had significantly greater response in subclinical infected animals 
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compared to control noninfected animals and clinical cows (Figure 5). The proteins with 
the highest reactivity were cysteine desulfurase (MAP2120c) and phage shock protein A 
(MAP2855), followed by Cfp29/linocin (MAP0630c) and the 22kDa putative lipoprotein 
(MAP1138). Clinical animals in general had low reactivity to proteins, with the greatest 
reactivity being observed for phage shock protein A (MAP2855c). Control animals had 
low OD readings to most proteins, and the highest reactivity was observed for the 22kDa 
lipoprotein (MAP1138).   
Humoral immune response to selected protein complex subunits. 
 Immuno-blots were performed with the recombinant proteins in an attempt to 
determine their antigenicity in the context of infection. In this analysis, several proteins 
demonstrated higher band intensities amongst the clinical group as compared to control 
animals and subclinical animals (Table 3). This is evident by the contrasting band 
intensities between these groups of proteins Acyl-CoA dehydrogenase (MAP0150) (p < 
0.05) and 22 kDa lipoprotein (MAP1138c) (p < 0.05). Clinical animals had an average 
band intensity of 3,402 for Acyl-CoA dehydrogenase, while the corresponding values in 
the control and subclinical groups were 413 and 455, respectfully. For 22 kDa 
lipoprotein, the average among clinical animals was 708 in contrast to 2 found in the 
control group. In general, subclinical animals had low band intensity indicating 
negligible antibody to proteins.  Two exceptions were phage shock protein A 
(MAP2855c), with an average band intensity of 1,706 and putative ATPase (MAP3844) 
with a band intensity of 1,506. 
Discussion. 
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 Using blue native PAGE and MS, putative membrane protein complexes of MAP 
were found and putative component proteins identified. This is the first study to 
characterize protein complexes in the envelope of MAP. Proteins that are co-located in a 
single protein complex can be reasonably thought of as interacting with each other at 
some level. Some interactions are fairly obvious, such as the MAP3698c and 
MAP3697c, which both encode subunits of the succinate dehydrogenase complex. 
Others need to be studied further to understand what the interaction means biologically 
(i.e. MAP2120c and MAP2121c). In this study, a total of seven putative protein 
complexes were identified. These results add another layer of detail to the organization 
of the mycobacterial cell wall.  
 Complex I was found to contain major membrane protein (MMP) encoded by 
MAP2121c, a characterized surface exposed protein of MAP. MMP has been shown to 
be involved in invasion of epithelial cells by MAP and to be recognized by sera of 
animals with paratuberculosis (21). Here we show that MMP forms a protein complex 
with a probable cysteine desulfurase (MAP2120c), an enzyme that removes elemental 
sulfur from cysteine for biosynthesis of a variety of co-factors (22).  This enzyme is 
classified as a group II desulfurase based on the consensus sequence (RAGHHCA) 
around the conserved Cys625 (22).  The Cys625 expressed from MAP2120c is the 
critical catalytic residue based on studies performed with other bacterial desulfurases 
(23). The inherent toxicity of free sulfide suggests the biogenesis of sulfur-containing 
co-factors is mediated by specific protein complexes (22) and perhaps complex I 
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containing the major membrane protein. Furthermore, both these genes are arranged in 
tandem on the MAP chromosome (18), and could be present in the same operon. 
 A protein homologous to MMP has also been found in M. leprae. Patients with 
leprosy were demonstrated to have both an antibody and an IFN-γ secreting T-cell 
proliferative response to this antigen (24). More recently, Shin et al. (25) observed high 
antibody titers to MAV2054, a protein with 100% sequence homology to MMP, in 
patients with M. avium-M. intracellulare complex (MAC) pulmonary disease and 
pulmonary tuberculosis. Data from the present study also suggests that MMP is a major 
antigen of MAP, having elicited both an antibody and an IFN-γ response in infected 
animals.  
Cysteine desulfurase (MAP2120c) showed the highest antibody recognition 
among animals across all infection stages and was among the highest in IFN-γ response. 
Collectively, these data suggest that complex I may be important in the pathogenesis of 
MAP and contain immunodominant antigens of this pathogen.  
A protein in Complex II was Cfp29 (MAP0630c), the mycobacterial homologue 
of linocin, a bacteriocin first identified in Brevibacterium linens (26). Cfp29 was found 
in the culture filtrate as well as membrane fractions of M. tuberculosis and was 
demonstrated to be a strong T cell antigen triggering the release of large quantities of 
IFN-γ from memory effector cells isolated during the recall of protective immunity in 
the mouse model of TB infection (27). In this study, Cfp29 also demonstrated strong T 
cell responses, eliciting high IFN-γ responses in subclinical animals. Also in complex II, 
a dye-decolorizing peroxidase (Dyp) type protein (MAP0631c) that is part of a novel 
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family of heme peroxidases was found. Although little research has been done regarding 
their function, this family of proteins appears to comprise bifunctional enzymes with 
hydrolase or oxygenase, as well as typical peroxidase activities (28). The interaction of 
these two proteins was predicted by String 9.05 due to co-occurrence in other organisms 
as well as tandem location of coding sequences within the genome. Considering the 
immune response to Cfp29 in animals infected with MAP characterized in this study, as 
well as the previous description of reactivity to this protein in tuberculosis infection (27), 
it is interesting to note that again an antigenic protein is found to be part of a complex. 
This provides clues as to the function of Cfp29 and how it may be structurally presented 
to the host during infection. 
Proteins of the succinate dehydrogenase complex were identified in complex III. 
This 4-subunit complex contains proteins involved in the citric acid cycle and in 
oxidative phosphorylation. In this study, the flavoprotein (MAP3698c) and iron-sulfur 
(MAP3967c) subunits of the complex were found. Upon studying membrane complexes 
of M. tuberculosis, Zheng et al. (29) also found the flavoprotein and iron-sulfur subunits 
of this complex associated with the mycobacterial envelope. In the present study, 
another succinate dehydrogenase subunit was found encoded by MAP3443. Other 
subunits of the succinate dehydrogenase complex found in the genome have genes 
located in the same region and are encoded by MAP3442, MAP3441 and MAP3444. 
This suggests that MAP may contain two different succinate dehydrogenase complexes.  
Glutamine synthetase (MAP1962) plays an essential role in the metabolism of 
nitrogen by catalyzing the reaction to convert glutamate and ammonia to form glutamine 
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and can form complexes of several identical subunits. In pathogenic mycobacteria, 
glutamine synthetase has been implicated as having a role in retarding phagosome 
acidification and phagosome−lysosome fusion (30). Additionally, it is believed to be 
involved in cell wall biosynthesis with the production of poly-L-glutamate−glutamine 
that is a major component of the cell wall in pathogenic mycobacteria (29), suggesting a 
major role in host-pathogen interactions during infection.   
Several proteins had greater reactivity in the subclinical group as compared to 
clinical animals and control animals in the IFN-γ assay, suggesting they may be good 
diagnostic targets when used in this assay. Among these proteins was phage shock 
protein A (MAP2855). This protein is part of the phage-shock protein response (Psp), a 
conserved system of many bacteria to respond to extracellular stress. In some pathogens 
such as Salmonella typhimurium, phage shock protein A (PspA) has been demonstrated 
to be essential for virulence and survival of the bacterium inside the macrophage (30). 
This protein demonstrated high reactivity in subclinical animals even at the lowest 
concentration (data not shown).  
MAP3290c encodes Mpt64, a protein characterized as an immune-dominant 
secreted antigen from M. tuberculosis. Several diagnostic assays for human tuberculosis 
have been developed using this protein, including immune-chromatographic assays to 
test for the protein in bacterial cultures, immunohistochemistry to identify the protein in 
tissues, and ELISA for detection of serum antibodies in infected patients (31). In the 
present study, Mpt64 was shown to be a strong T cell antigen with IFN-γ responses, as 
well as high reactivity in Western blots, demonstrating promise as a candidate for 
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diagnostic development. Chen et al. (32) investigated a mutant strain of MAP with a 
MAP3290c gene deletion as an attenuated vaccine for paratuberculosis. The deletion 
resulted in a more rapid elimination of the bacterium in mice in comparison to the wild-
type strain, suggesting Mpt64 has an important role in pathogenesis.  
The present study is the first to investigate protein complexes in the envelope of 
MAP. Seven putative protein complexes were found along with the identification of 
several novel antigenic proteins. The finding that some proteins such as MMP 
(MAP2121c) and Cfp29 (MAP0630c) are part of complexes provides some information 
as to their interactions with other proteins and possible associations with bacterial 
virulence. Some proteins, such as MMP (MAP2121c) demonstrated antigenicity 
dependent upon stage of infection, suggesting they are differentially regulated during the 
course of infection. This study illuminates an important compartment of MAP, the cell 
envelope, that is crucial for the pathogenesis of the bacterium and likely holds the initial 
antigens the host encounters upon infection. 
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Figure 1. Blue native gel stained with Coomassie demonstrating the different complexes 
found. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
 
Figure 2. Second dimension SDS-PAGE gel with identified protein spots. Molecular 
weight ladder is marked on left. Roman numerals on top of gel indicate blue native gel 
bands. 
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Table 1. Summary of proteins identified by MS in each complex (band) of blue native 
gel. 
Protein 
Description 
Gene 
Protein 
molecular 
weight (kDa) 
Total 
number 
of spectra 
Number 
of unique 
peptides 
Percent 
sequence 
coverage 
Predicted 
Trans-
membrane 
Helices 
Complex I       
Major 
membrane 
protein* 
MAP_2121c 34 71 14 61.90 0 
Probable 
cysteine 
desulfurase* 
MAP_2120c 72 58 13 34.30 0 
Complex II       
Linocin/Cfp 
29* 
MAP_0630c 29 110 17 76.20 0 
Dyp-type 
peroxidase 
family 
MAP_0631c 36 16 4 20.20 0 
Putative RND 
superfamily 
drug 
exporter* 
MAP_3641c 102 9 3 2.51 10 
Putative 
exporter of 
polyketide 
antibiotics* 
MAP_2561 56 5 2 6.03 12 
Protein 
translocase 
subunit SecF* 
MAP_1044 46 6 2 9.66 6 
ABC-type 
multidrug 
transport 
system, 
ATPase 
component 
MAP_3465 85 5 2 3.41 6 
Daunorubicin 
resistance 
ABC 
transporter 
ATP-binding 
subunit 
MAP_1238c 33 4 2 6.98 0 
Arabinose 
efflux 
permease 
family protein 
MAP_1596 72 3 2 4.70 13 
Type VII 
secretion 
integral 
membrane 
protein EccD 
MAP_1510 53 3 2 5.77 11 
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Table 1. continued 
 
Transport 
protein 
MAP_1240c 105 2 2 2.28 12 
Complex III       
Succinate 
dehydrogenas
e/fumarate 
reductase 
flavoprotein 
subunit* 
MAP_3698c 71 86 22 38.50 0 
FadA2 MAP_3693 47 14 3 11.60 0 
Succinate 
dehydrogenas
e and 
fumarate 
reductase 
iron-sulfur 
protein* 
MAP_3697c 29 29 8 37.90 0 
SppA* MAP_4188 63 37 11 26.20 0 
Putative 
uncharacteriz
ed protein 
MAP_3699c 32 8 3 12.00 5 
Complex IV       
Succinate 
dehydrogenas
e, 
flavoprotein 
subunit* 
MAP_3443 64 15 4 7.02 0 
Rieske Fe-S 
protein* 
MAP_1934 44 11 3 11.70 3 
3-oxoacyl-
(Acyl-carrier 
protein) 
reductase* 
MAP_2332c 328 4 2 0.84 0 
Glycerol-3-
phosphate 
dehydrogenas
e* 
MAP_3423c 63 5 3 5.14 0 
Preprotein 
translocase, 
SecE subunit* 
MAP_4110 16 5 2 15.60 1 
Complex V       
Bacterioferriti
n 
MAP_1595 18 45 9 61.60 0 
Isocitrate 
lyase* 
MAP_1643 85 26 10 17.20 0 
Fe-S 
oxidoreductas
e* 
MAP_3831c 103 12 3 5.42 5 
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Table 1. continued 
Gel diffusion was observed with some proteins being found in more than one complex, 
when this occurred a * is marked next to the protein. Proteins were assigned to 
complexes based on presence on that band and higher number of spectra present within 
the assigned band. The full list of all identified proteins and three replicate MS runs can 
be found in supplemental file S1. 
Putative 
uncharacteriz
ed protein* 
MAP_0212 70 28 7 15.90 2 
Pyridoxal 
biosynthesis 
lyase PdxS 
MAP_2710c 32 17 5 23.10 0 
Putative 
membrane 
protein 
MAP_1016c 65 9 2 3.70 5 
Putative 
uncharacteriz
ed protein 
MAP_1689 44 6 3 9.98 0 
Complex VI       
Glutamine 
synthetase* 
MAP_1962 54 20 6 19.00 0 
Complex VII       
FadA2* MAP_3693 47 31 8 24.80 0 
FadD15* MAP_1925 65 13 3 7.33 0 
FabG4 MAP_3692c 47 11 3 10.40 0 
FadE25_2* MAP_0150c 44 202 17 54.30 0 
FadE3 MAP_3651c 41 4 2 8.38 0 
Putative 
uncharacteriz
ed protein* 
MAP_3972c 37 8 2 11.40 1 
ATP synthase 
subunit alpha 
MAP_2453c 60 9 3 9.03 0 
Glycosidase MAP_2433 77 18 6 12.50 0 
22 kDa 
lipoprotein 
MAP_1138c 24 17 4 21.80 0 
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Table 2. Identified proteins by MS on 2D SDS-PAGE gels.  
Spot 
ID Protein Description Gene 
Protein 
molecular 
weight 
(kDa) 
Number 
of unique 
peptides 
Percent 
sequence 
coverage 
2 Phage shock protein A  MAP_2855c 29 2 10.50 
4 Probable cysteine desulfurase  MAP_2120c 71 3 7.60 
5 Major membrane protein MAP_2121c 33 8 38.10 
9 Linocin/CFP29  MAP_0630c 28 4 16.60 
10 Putative uncharacterized protein  MAP_3290c 21 2 13.20 
15 Acyl-CoA dehydrogenase  MAP_4214c 41 2 16.30 
17 Non-ribosomal peptide synthase  MAP_3482 73 2 3.65 
18 grpE  MAP_3841 23 2 28.60 
20 Putative ATPase  MAP_3844 154 2 2.44 
21 Bacterioferritin  MAP_1595 18 7 58.50 
23 
Adenosine deaminase 
(Fragment)  MAP_2443 54 2 8.08 
25 
Methyltransferase, cyclopropane 
fatty acid synthase  MAP_3963 32 2 13.60% 
28 Acyl-CoA dehydrogenase  MAP_0150c 43 3 8.44% 
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A) 
 
B) 
  
C) 
 
                                                             
Figure 3. Confidence view generated by String 9.05 software of interaction between A) 
probable cysteine desulfurase (MAP2120c) and major membrane protein (mmpI), B) 
Cfp29 (MAP0630c) and Dyp-type peroxidase family protein (MAP0631c), C) FadA2 
(MAP3693), FadD15 (MAP1925) and FabG4 (MAP3692c). The stronger predicted 
association between proteins is represented by thicker lines. 
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Figure 4. Representative western-bot of each group along with silver stain reference 2D 
gel. Main protein spots recognized are identified. Spot 4: Cysteine desulfurase 
(MAP2120c), 5: Major membrane protein (MAP2121c), 9: Cfp29 (MAP0630c), 10: 
Mpt64 (MAP3290c), 21: Bacterioferritin (MAP1595c).
  
 
Table 3. Protein spots reactive on 2D gels revealed by Western-blot with sera from control (n=10), subclinical (n=9) and 
clinical (n=13) non-infected animals.  
a
 % positive= number of serum samples that reacted positively on Western-blot of total serum samples in that infection group.
Spot number, protein description  
and coding sequence  
Control Cows 
% positive
a
  
Sub Clinical Cows 
% positive
a
  
Clinical cows 
% positive
a
  
4, Probable Cysteine desulfurase, MAP2120c  100 (10/10) 77.8 (7/9) 100 (13/13) 
21, Bacterioferritin, MAP1595c 60 (6/10)  55.6 (5/9) 92.3 (12/13) 
10, Mpt64, MAP3290c 40 (4/10)  44.4 (4/9) 61.5 (8/13) 
5, Major Membrane Protein, MAP2121c 10 (1/10)  22.2 (2/9) 61.5 (8/13) 
33, No ID 20 (2/10)  22.2 (2/9) 15.4 (2/13) 
1, No ID 20 (2/10)  33.3 (3/9) 38.5 (5/13) 
28, Acyl-CoA dehydrogenase, MAP0150  20 (2/10)  33.3 (3/9) 7.6 (1/13) 
6, No ID 0 (0/10) 11.1 (1/9) 7.6 (1/13) 
20, Putative ATPase, MAP3844 0 (0/10) 0 (0/9) 15.4 (2/13) 
9, Linocin/Cfp29, MAP0630c 40 (4/10) 33.3 (3/9) 7.6 (1/13) 
6
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Figure 5. Interferon gamma release assay of recombinant proteins tested at 10µg/ml with 
animals of clinical (n=6), subclinical (n=5) and noninfected control (n=6). OD readings 
of responses to proteins with positive values after correcting for MBP and medium to the 
stimulation. Error bars represent standard error of the mean. Different letters indicate 
statistical significance (p <0.05). 
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Table 4. Band intensity of proteins in slot blots with control (n=5), subclinical (n=7) and clinical (n=5) non-infected animals. 
Protein ID Control  Subclinical Clinical 
Cysteine desulfurase-2 (MAP2120c) 2,389 (±711)a 330 (±216)a 9,758 (±3096)a 
Cysteine desulfurase-3 (MAP2120c) 708 (±343)a 181 (±101)a 6,958 (±2741)a 
Linocin/Cpf59 (MAP0630c) 17 (±16)b 398 (±280)b 2,449 (±914)a 
Bacterioferritin (MAP1595) 2,379 (±1032)a 196 (±194)a 6,931 (±3421)a 
Major membrane protein (MAP2121c) 1,019 (±571)a 413 (±155)a 6,303 (±3024)a 
Acyl-CoA dehydrogenase (MAP0150) 413 (±268)b 455 (±448)b 3,402 (±1403)a 
Putative ATPase (MAP3844) 1,015 (±920)a 1,506 (±1197)a 3,573 (±2487)a 
Mpt64 (MAP3290c) 4,542 (±4466)a 72 (±48)a 944 (±925)a 
Phage shock protein A (MAP2855c) 121 (±77)a 1,706 (±846)a 5,116 (±3768)a 
22 kDa lipoprotein (MAP1138c) 2 (±1.8)b 12 (±7.2)b 708 (±708)a 
MAP complete homogenate 51 (±23.84)b 1900 (±1869)a 5356 (±2201)a 
MAP envelope preparation 999 (±522)a 1274 (±555)a 9066 (±3365)a 
 
Averages followed by standard error of the mean in parenthesis. Different letters indicate statistical significance (p <0.05) 
Band intensity of each animal was measured after subtracting background of maltose binding protein control reactivity, if a 
negative value was obtained it was substituted with the value of zero. Averages represent the band intensities of all animals in 
each infectious stage category.  
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Abstract. 
 Paratuberculosis is a chronic intestinal disease of ruminant animals caused by 
Mycobacterium avium subsp. paratuberculosis (MAP). A hallmark of paratuberculosis is 
a transition from a cell-mediated Th1 type response to a humoral Th2 response with the 
progression of disease from a subclinical to clinical state. The objective of this study was 
to investigate the expression of two crucial molecules in T cell function, ZAP-70 (zeta-
chain associated protein of 70 kDa) and CTLA-4 (cytotoxic T-lymphocyte antigen-4), in 
cows naturally infected with MAP. Peripheral blood mononuclear cells (PBMCs) 
isolated from control non-infected cows (n=5), and cows in clinical (n=6) and 
subclinical stages of paratuberculosis (n=6) were cultured alone (medium only), with 
concanavalin A, and a whole cell sonicate of MAP for 24, 72 and 144 hours to measure 
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the dynamic changes of ZAP-70 and CTLA-4 expression on CD4, CD8, and gamma 
delta () T cells. Flow cytometry was also performed to measure ZAP-70 
phosphorylation to examine proximal T cell receptor signaling in animals of different 
disease status. It was found that the surface expression of CTLA-4 is dramatically 
increased in animals in subclinical stage of infection while levels of ZAP-70 are 
significantly decreased in CD4+ T cells of both subclinical and clinical animals, 
indicating a change in T cell phenotype with disease state. Interestingly, proximal T cell 
receptor signaling was not altered in infected animals. This study demonstrates changes 
in crucial signaling molecules in animals infected with MAP elucidating T cell 
alterations that are associated with disease progression.   
 
Introduction. 
 Paratuberculosis, also called Johne’s disease, is a disease of ruminant animals 
caused by the bacterium Mycobacterium avium subsp. paratuberculosis (MAP). 
Paratuberculosis is a chronic enteric disease with high economic impact in US dairy 
cattle, where it can cause decreased milk production, lead to early culling of animals, 
and reduce fertility rates (1). The disease is primarily subclinical, and clinical signs such 
as diarrhea and weight loss can take from 2 to 5 years to manifest (2). The disease has 
worldwide distribution in most ruminant species, and prevalence of paratuberculosis at 
the dairy herd level in the US is estimated to be 91.1% (3).  
Infection of ruminant animals occurs primarily via exposure to contaminated 
feces or ingestion of colostrum/milk from infected dams (2).  Upon infection, MAP 
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passes through the M cells in the small intestine where it is phagocytized by 
macrophages within the submucosa (4). Initially, animals control infection with a Th1 
response predominated by secretion of cytokines such as IFN-γ that activate 
macrophages to allow killing of the intracellular bacterium (5). As disease progresses 
and clinical manifestations begin to occur, there is a shift from a cell-mediated Th1 to a 
non-protective Th2 response characterized by antibody titers to MAP. The molecular 
mechanisms underlying this transition are poorly understood (6). Previous research has 
also found that cells isolated from animals with clinical disease neither secrete IFN-γ 
when stimulated with MAP antigen, nor proliferate or respond to T cell mitogens such as 
concanavalin A (7,8). This suggests that there are other mechanisms involved in T cell 
function during the progression of disease other than simply the shift to a Th2 response, 
and these may include the induction of tolerance and anergy/hypofunction of T cells. 
ZAP-70 (zeta-chain associated protein of 70 kDa) and CTLA-4 (cytotoxic T-
lymphocyte antigen-4) are two critical components of the T cell that are involved in 
modulation of host immune responses (9,10).  Upon engagement of the T cell receptor 
with an antigen presented by a MHC molecule of an antigen presenting cell, ZAP-70 is 
directed to ITAMS (immuno-receptor tyrosine-based activation motifs) of the zeta chain 
of the CD3 receptor, after which it is activated by phosphorylation and invokes 
downstream signaling molecules of the T cell leading to its full activation (9). Depletion 
studies have demonstrated that in the absence of ZAP-70 a functional immune synapse 
cannot occur, resulting in retardation of cell activation with subsequent impacts on 
ability of the cell to secrete cytokines or carry out effector functions (11). CTLA-4 is 
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regarded as a major negative regulator of T cell responses and its co-ligation with the T 
cell receptor (TCR) can induce anergy (12). Its inhibitory function occurs by 
engagement of B7 ligands (CD80/CD86) expressed on antigen presenting cells, resulting 
in inhibition of cytokine production and T cell proliferation (13).  These two molecules 
work together to either allow T cell activation (ZAP-70) or to abrogate T cell responses 
(CTLA-4). 
The present study was designed to measure signaling molecules of T cell 
activation, ZAP70 and CTLA-4, through flow cytometry in cows in different stages of 
disease.  Mechanisms of cellular activation were further explored by quantifying the 
phosphorylation of ZAP70 following activation of cells to determine if the signaling 
cascade was compromised. This is the first study to examine these positive and negative 
T cell regulators in Johne’s disease. Our findings suggest these molecules may be 
responsible for the immune shift that occurs in progression from subclinical to clinical 
Johne’s disease. 
Materials and Methods. 
Animals. 
  Holstein dairy cows used in this study were placed in three groups based on stage 
of disease. This consisted of noninfected healthy cows (n = 5), cows naturally infected 
with M. avium subsp. paratuberculosis but asymptomatic (n = 6) (i.e., subclinical stage), 
and cows with clinical signs of paratuberculosis (n = 6). Animals were classified as 
clinical or subclinical based upon results from interferon gamma release assay, serum 
antibody, and fecal culture. On average, cows in the study were 6 years of age with 3-4 
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lactation periods.  All animals were housed at the National Animal Disease Center 
(Ames, IA).  Cows infected with MAP were housed separately from healthy control 
cows to prevent cross-contamination between groups. All animal-related procedures 
were approved by the IACUC of the National Animal Disease Center (Ames, IA).  
Blood collection, culture conditions, and sample collection.  
 Blood was collected from the jugular vein in 2X acid citrate-dextrose solution 
(1:10) and used for isolation of peripheral blood mononuclear cells (PBMCs) from the 
buffy coat as previously described (14). These cells were resuspended to 2x10
6
 cells/ml 
in complete RPMI-1640 medium (Life technologies, Carlsbad, CA) supplemented with 
100 units/mL of penicillin, 100 µg/mL of streptomycin, and 0.25 µg/mL of Fungizone® 
(Gibco, Carlsbad, CA). Cell culture was performed in 6 well flat-bottomed plates at 
39°C in 5% CO2 in a humidified atmosphere. In vitro treatments consisted of no 
stimulation (NS; medium only), concanavalin A (ConA) (10µg/ml; Sigma St. Luis, 
MO), and whole-cell sonicate of MAP prepared as previously described (15) (MPS; 10 
µg /ml). Plates were incubated for 24, 72 and 144 hours and cells were harvested for 
flow cytometric analyses.  During the last 5 hours of incubation a cocktail of 10 µg/ml 
brefeldin A (Sigma), 1 µg/ml ionomycin (Sigma) and 50 ng/ml PMA (Sigma) was added 
to enable intracellular measurement of IFN-γ. 
 Flow cytometric measurement of ZAP, pZAP70, CTLA-4, and IFN-.  
Cells were gently removed from culture plates by pipetting and resuspending 
cultures in phosphate buffered saline (PBS). These were then counted on a Z2 Coulter 
Particle Count and Size Analyzer (Beckman Coulter). One million cells were added per 
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well in a 96 well round bottom plate (Corning Incorporated) followed by 50 µl cocktail 
of primary antibodies to T cell surface markers CD4, CD8, gamma delta T cell receptor 
(TCR) (WSU Monoclonal Antibody Center) and CTLA-4 (Ancell) (Table 1). After a 
15 min incubation at room temperature (RT), plates were centrifuged for 2 min at 400 x 
g, the supernatant was decanted, and 50 µl of a secondary antibody cocktail was added, 
including PE-Cy7 anti-mouse IgM (5 µl/ml; Southern Biotech), APC Cy7 anti-mouse 
IgG2b (7 µl/ml; Southern Biotech), Alexa Fluor 350 anti-mouse IgG1 (25 µl/ml; Life 
Technologies). After incubation for 15 min at RT, plates were centrifuged as described 
above then fixed and permeabilized following manufacturer’s instructions with the 
Cytofix/Cytoperm solution (BD Biosciences). Cells were washed twice with Perm/Wash 
buffer (BD Biosciences), followed by intracellular staining for 30 min at 4°C for the 
molecules ZAP-70, phosphorylated ZAP-70 (pZAP-70), and IFN-γ. After another two 
washes with Perm/Wash buffer (BD Biosciences) cells were resuspended in PBS with 
0.4% sodium azide for flow cytometric analysis. Samples were evaluated using 10,000 
events per sample, using a FACScan flow cytometer (CellQuest software; Becton, 
Dickinson). Analyses were conducted by gating on live cells based upon forward and 
side scatter characteristics (FlowJo; Tree Star). Due to the low level of live cells in the 
ConA treatment at 144 hr culture this treatment was not considered for analysis.   
Phospho flow cytometric analysis of pZAP-70.    
 To measure ZAP-70 phosphorylation during T cell activation, the technique of 
phospho flow cytometry was used following a modified protocol (16). Isolated PBMCs 
were plated at 2 x 10
6
/ml in 96 well round bottom plates in RPMI 1640 medium (Life 
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technologies) and allowed to rest for one hour at 39°C in 5% CO2. No fetal bovine serum 
was present in the medium in order to reduce baseline ZAP-70 phosphorylation. T cell 
activation was performed with anti-CD3 (10 µg/ml; MM1A), MAP whole-cell sonicate 
(MPS; 10 µg/ml), and the inclusion of 11 mM hydrogen peroxide as a positive control to 
induce non-specific tyrosine phosphorylation. After addition of different treatments, 
cells were incubated for 15 min at 39°C in 5% CO2 in a humidified atmosphere. This 
was followed by fixation of the cells to halt phosphorylation events with 
Cytofix/Cytoperm solution (BD Biosciences). After cells were fixed and permeabilized, 
cell staining followed the protocol of cultured cells for staining of pZAP-70 and ZAP-70 
within CD4, CD8 and  TCR T cells (Table 1). A substitution of CD8 clone MCA837 
(Serotec) was made as the clone CACT80C (WSU Monoclonal Antibody Center) does 
not stain cells that have been previously fixed. A time trial determined that at 15 min the 
maximum cell activation as measured by ZAP-70 phosphorylation was achieved (data 
not shown), thus this was the time allowed for cell activation used for the experiments.   
Statistical Analysis. 
 Data were analyzed using the PROC Mixed function of SAS 9.02 (SAS Institute, 
Cary, NC) 144hr culture was analyzed in a separate model because of the lacking ConA 
treatment and higher variance within samples. Two-sided P < 0.05 values were 
considered significant. 
Results  
T cell expression of Zap-70 after stimulation for 24, 72 and 144 hr. 
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 After 24 h culture, both clinical and subclinical animals had significantly (P < 
0.05) fewer ZAP-70 + CD4 T cells regardless of the in vitro treatment. This trend was 
also true for CD8 and  T cells, although with less marked difference and without 
statistical significance (Figure 1). Expanding PBMC culture time to 72 and 144 hr 
resulted in increased percentages of CD4+ T cells expressing ZAP-70 for the clinical and 
subclinical groups to a level similar to non-infected animals after stimulation of cells 
with MPS (Figure 2a). However, this effect was not observed for pZAP-70 expression 
(Figure 2b). Further, differences in pZAP70 expression were not observed for  CD8+ 
and  TCR+ T cells  regardless of animal treatment group (data not shown).  
Analysis of CTLA-4 and IFN-γ expression in T cells of 24, 72 and 144 hr cultures. 
 Surface expression of CTLA-4 was measured in CD4, CD8, and  T cell subsets 
throughout the different time points. In 24 hr cultures, the subclinical group had more 
CD4+ and CD8+ T cells expressing CTLA-4 than the clinical and control group (Figure 
3). The marked difference observed in CTLA-4 expression between infection groups 
observed in CD4+ T cells is also demonstrated in flow cytometry density plots of Figure 
5. The surface expression of CTLA-4 was negligible among T cells (Figure 3). In 
cultures of 72 and 144 hrs, the subclinical group maintained the trend of being the group 
with the highest CTLA-4 expression and the number of cells expressing CTLA-4 went 
down (Figure 3). Because this negative regulator of T cells is expressed at a higher level 
in subclinical cows, this could suggest that MAP utilizes this as an escape mechanism 
for survival in the host. Trends were harder to identify within intracellular IFN-γ 
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expression, although levels of this cytokine did increase over time within CD4+ T cells 
isolated from clinical and subclinical animals and stimulated with MPS (Figure 4). 
Phospho flow cytometry and measurement of ZAP-70 phosphorylation. 
To address proximal T cell receptor signaling and T cell activation, phospho flow 
cytometry was performed to measure phosphorylation of ZAP-70 following TCR (T Cell 
Receptor) engagement. This is one of the first events in the signaling cascade of T cells, 
and is necessary to promote cell activation and effector functions. Hydrogen peroxide 
was used as positive control and anti-CD3 antibody to measure the activation capacity of 
the cell in an antigen independent manner. Within the CD4+ cell subset, hydrogen 
peroxide was the treatment with the highest phosphorylation, followed by the anti-CD3 
treatment; and both were statistically significant (p < 0.05) in relation to the NS 
treatment for the clinical and control groups (Figure 6). No statistical significance was 
observed between the MPS and NS treatments. In  TCR + T cells, all animal groups 
responded to anti-CD3 and hydrogen peroxide treatments, with statistical significance to 
both in relation to the NS control. CD8+ cells were the only subset of the three T cell 
populations to have responded more to anti-CD3 antibody than hydrogen peroxide 
(Figure 6). And this treatment had statistically higher responses (p<0.05) in relation to 
all treatments for control, subclinical and clinical animals.  
Discussion 
Studies in paratuberculosis have provided evidence towards anergy or T cell 
hypofunction with disease. Weiss et al. (7) studied the phenotype and response of 
mononuclear leukocytes from the ileum of cows naturally infected with MAP. 
79 
 
 
Lymphocytes isolated from the ileum of infected cows did not proliferate when 
incubated with MAP antigen, demonstrating a hyporesponsive state of these cells 
correlating with anergy (7). In a study to investigate the immune response to MAP in 
naturally and experimentally infected sheep, Begg et al. (8) found similar 
hyporesponsiveness in animals in more advanced stages of disease. Animals had 
decreased IFN-γ production and reduced ability to proliferate in response to MAP 
antigen and pokeweed mitogen (PWM). Interleukin-12 was also added to the cell 
cultures in an attempt to aid their stimulation; however, addition of the cytokine had no 
significant effects on the cellular responses (8). In paratuberculosis there are a limited 
number of studies that have addressed potential alterations within T cells and the events 
leading to clinical disease. Yet this information is critical to providing a better 
understanding of the disease as well as the possibility of more targeted approaches for 
vaccine and therapeutic development.   
Leprosy is a mycobacterial disease that shares an analogous transitory immune 
response similar to paratuberculosis. Patients with early stage infection and tuberculoid 
leprosy possess a cell-mediated immunity (CMI) that is considered to be effective in 
controlling disease. While there is a transition to a Th2 type response with decreased 
CMI responses in patients as bacterial load increases and patients evolve to the more 
severe lepromatous leprosy phase in which clinical signs of disease become evident and 
T cell hypofunction has been observed (17).  Kumar et al. (18) demonstrated that 
patients with advanced forms of leprosy had significantly less pZAP-70 and ZAP-70 
present in their T cells. Along with this finding, Cbl-b was also shown to be upregulated 
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in diseased patients. Cbl-b is an ubiquitin ligase and potent negative regulator of T cell 
function that is present in most anergic T cells (19). By imunnoprecipitaion it was shown 
that ZAP-70 was associated with this molecule in T cells of diseased patients (18). 
Considering the importance of ZAP-70 in T cell signaling, it would be expected that the 
T cells identified as being ZAP-70 negative have a decreased potential for activation and 
effector function potentially being rendered anergic. 
 In the present study, the finding that cows infected with MAP had fewer ZAP-70 
+ T cells, especially CD4+ cells, is indicative of an immunological change in the cells of 
these animals. Several different mechanisms could be involved including protein 
interactions such as ubiquitination. With longer times in culture both subclinical and 
clinical animals had increased percentages of ZAP-70 + CD4+ T cells. This increase 
may be due to the death of cells that lacked ZAP-70 in culture or the loss of an inhibition 
factor leading to decreased expression of the molecule. Interestingly, the baseline levels 
of ZAP-70 phosphorylation remained lower among infected animals as compared to 
control non-infected animals throughout the different culture periods. 
 Expression of CTLA-4 on T cells was markedly increased in animals with 
subclinical paratuberculosis. The difference observed between subclinical and clinical 
animals as well as control non-infected animals was more prominent within the CD4+ 
population. Expression of CTLA-4 in  T cells has been investigated in cattle, however 
with varied results. Howard et al. (20) did not find expression of CTLA-4 or the related 
CD28 molecule among bovine  T cells, similar to the results of Hanrahan et al. (21) 
who found negligible expression of these molecules in sheep  T cells. Blumerman et 
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al. (22) reported that the co-stimulation requirements of bovine  T cells differ from 
CD4+ and CD8+ cells, and also did not find CD28 within bovine  T cells, which is 
suggestive that a potential role of CTLA-4 among these cells could be different. This 
study however did find CTLA-4 mRNA within bovine  T as did Fikri et al. (23). 
Together this indicates that the expression of CTLA-4 within bovine  T cells is likely 
variable, a probable reason why in this study very low expression of the molecule was 
found. Another aspect that needs to be considered is that previous studies did not 
measure CTLA-4 on the surface of cells as performed in this study, rather mRNA levels 
were measured, most of CTLA-4 is contained within the cell as surface expression is 
tightly regulated because of its impacts on T cell function (24). The decreased 
expression of the molecule over time observed in the different T cell subsets was 
expected. Previous studies in mice and human cells have demonstrated that upon T cell 
activation the maximal surface expression of CTLA-4 occurs following 48-72 hrs of cell 
activation, followed by reduced expression with longer incubation periods (25, 26). In 
this study, maximal expression was found at 24 hrs possibly due to a difference of the 
bovine species in comparison to mouse and human and/or stimulation conditions. It is 
interesting to note that the expression of IFN-γ followed a reciprocal pattern compared to 
CTLA-4 expression, with higher levels of intracellular IFN-γ attained as time in culture 
increased. This may be due to the negative effects CTLA-4 has on cytokine production. 
Specifically, blocking of the CTLA-4 receptor has been shown to increase IFN-γ 
production in T cells (27). CTLA-4 could induce lower levels of IFN-γ expression in 
animals with paratuberculosis, as may be suggested from the results of this study. 
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Perhaps it is not a coincidence that the CD4+ T cells were the subset with the 
highest CTLA-4 expression. This is the same population (T helper cell) that would be 
expected to play a bigger role in directing a Th1 type response through macrophage 
activation. Considering the effects that CTLA-4 has on T cell function, MAP may induce 
a higher expression of CTLA-4 in T cells of infected animals as an evasion strategy from 
the immune system to promote chronic infection. Interestingly, in patients with leprosy 
similar observations were made. Palermo et al. (28) found the same pattern of CTLA-4 
expression in which patients with tuberculoid leprosy expressed significantly more 
CTLA-4 compared to lepromatous patients (28). As suggested in that study and in 
corroboration with data from this study, CTLA-4 expression may be involved in the 
induction of T cell hypofunction during early and mid-stages of infection, while likely 
other molecules could be involved in the maintenance of an anergic T cell state in the 
later stages of chronic infection. Programmed death-1 (PD-1) is a cell surface molecule 
that regulates adaptive immune response and is related to T cell exhaustion, a state that, 
contrary to anergy, is progressive, with dysfunction worsening overtime (29).  
Also pertinent to paratuberculosis infection are other roles that CTLA-4 has been 
demonstrated to have in T cells, especially those of the Th1 phenotype. Oosterwegel et 
al. (30) demonstrated that CTLA-4 has a critical role in CD4+ T cell differentiation. In 
contrast to wild type mice, T cells from CTLA-4 knockout mice produced IL-4 during 
primary stimulation with cells differentiating into almost pure populations of Th2 cells 
(30). This study suggested that B7 binding to CTLA-4 blocks Th2 differentiation. Thus 
the expression of this molecule among the subclinical group may serve the purpose of 
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inhibiting a Th2 differentiation bias of these cells. Also regarding CD4+ T cell 
phenotypes, Knieke et al. (31) demonstrated that CTLA-4 has a positive effect on Th1 
cell migration. It was found that crosslinking of CTLA-4 together with CD3 and CD28 
stimulation on activated Th1 cells increased expression of the chemokine receptors 
CCR5 and CCR7, which in turn enhanced cell migration sites of inflammation two-fold 
over CTLA-4 negative counterparts. These results suggest that CTLA-4 can orchestrate 
specific migration of selected Th1 cells to sites of inflammation and antigenic challenge. 
This may provide an explanation of how animals in the subclinical stage can control 
infection if T cells expressing high levels of CTLA-4 are efficiently migrating to target 
sites of infection.  
In addition, cells that express CTLA-4 have been shown to have extrinsic 
functions causing downregulation in other cells. This includes the induction of 
indoleamine 2,3 dioxygenase (IDO) activity in APCs, which leads to tryptophan 
catabolism that can inhibit other T cells from proliferating (32). This may also be an 
immune alteration caused by the increased CTLA-4 + T cells in animals infected with 
MAP as increased IDO activity has been described in animals with paratuberculosis 
(33).     
The lack of changes in proximal T cell receptor signaling as measured by TCR 
activation and ZAP-70 phosphorylation between infected and control animals in this 
study is not necessarily surprising. Hanschen et al. (34) also used phospho flow 
cytometry to compare T cell receptor signaling among regulatory T cells (Treg) and non-
Treg CD4+ cells. Interestingly, they found that T cell activation by anti-CD3 antibody 
84 
 
 
induced a response in ZAP-70 phosphorylation with higher magnitude in Tregs 
compared to non-Treg cells. Also, it was found that antigen-specific TCR stimulation 
did not significantly activate these signaling pathways, similar to what is reported here. 
Coussens et al. (35) reported an elevated number of Treg cells in PBMCs of animals 
infected with MAP but failed to discriminate between cows in subclinical or clinical 
stages of infection. The elevated number of Tregs present in infected animals may 
explain why there was no alteration in proximal T cell signaling in this study, with the 
clinical group yielding the highest phosphorylated ZAP-70 response in CD4+ T cells 
following anti-CD3 activation. Although not statistically significant, it was interesting to 
note differences between control and clinical animals in CD4+ cells, when comparing 
the anti-CD3 treatment to the hydrogen peroxide treatment. The hydrogen peroxide 
treatment, as a positive control, may represent the full potential of cells for ZAP-70 
phosphorylation. When comparing the anti-CD3 to the hydrogen peroxide treatment, 
control animals had similar stimulation values for both treatments while in clinical 
animals the hydrogen peroxide treatment was markedly higher. This demonstrates that 
potentially clinical animals may have a decreased capacity of proximal T cell receptor 
signaling as the full potential of activation was not achieved with the anti-CD3 
treatment. A subject for future investigation is if MAP has the ability to directly inhibit 
ZAP-70 phosphorylation as has been described in M. tuberculosis. Mahon et al. (36) 
demonstrated that pre-incubation of T cells with M. tuberculosis mannosylated 
lipoarabinomannan (Man-LAM) inhibits ZAP-70 phosphorylation, a mechanism likely 
due to insertion of Man-LAM into the membrane of target T cells. This may be a 
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possible mechanism of MAP as well, considering Man-LAM from this organism has 
also been shown to invoke cellular immunity (37).     
 This study investigated crucial molecules involved in T cell function in the 
context of paratuberculosis. Very few studies have addressed T cell function in 
paratuberculosis, especially T cell signaling events. Surprisingly, findings from this 
study correlate very well with findings from other studies in leprosy, suggesting the 
etiological agents of both diseases share similar mechanisms of immune evasion to cause 
chronic infection. This study for the first time discovered alterations in two crucial 
signaling molecules of the T cell in animals infected with MAP, shedding light into 
immune alterations that occur and possible triggers that lead to clinical paratuberculosis.      
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Table 1. Primary antibodies used in study. 
Target IgG type Working 
conc. 
Clone Fluorochrome 
used 
CD4 IgM 10 µl/ml CATC83B PE-Cy7 
 
CD8 
 
IgG1 
 
10 µl/ml 
 
CACT80C 
 
Alexa 350 
 
CD8 
 
IgG2a 
 
20 µl/ml 
 
MCA837 
 
Alexa 350 
 
TCR 
 
IgG2b 
 
10 µl/ml 
 
GB21A 
 
APC Cy7 
 
CTLA-4* 
 
IgG1 
 
8 µl/ml 
 
ANC152.2/8H5 
 
PerCp 
 
ZAP-70* 
 
IgG1 
 
10 µl/ml 
 
1E7.2 
 
Pacific Blue 
 
IFN-g* 
 
IgG1 
 
20 µl/ml 
 
MCA1783PE 
 
PE  
 
pZAP-70* 
 
Rabbit 
polyclonal  
 
10 µl/ml 
 
Polyclonal to 
Y319 
 
Alexa488 
* Directly conjugated. Surface marker antibodies were diluted in PBS with 0.4% sodium 
azide, intracellular markers ZAP-70, phosphorylated ZAP-70 (pZAP-70) and IFN-γ were 
diluted in BD Perm Wash Buffer. CTLA-4 conjugated to PerCp with the Easy link 
PerCP conjugation kit (Abcam, Cambridge, ENG). pZAP-70 conjugated to Alexa 
Flour® 488 with the Alexa Fluor® 488 Antibody Labeling Kit (Life technologies, 
Carlsbad,CA). 
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Figure 1. Expression of ZAP-70 studied in 24 hours cell culture obtained from healthy 
control cows and cows naturally infected with MAP in the subclinical and clinical stages 
of infection. A) CD4+ T cells. B) CD8+ T cells. C)  TCR+ T cells. Data are presented 
as percentage of ZAP70+ T cells (mean ± SEM).  Significant differences between 
treatment groups are designated by asterisk *, **(P < 0.05). 
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Figure 2. Expression of ZAP-70 (A) and pZAP-70 (B) on CD4+ T cells isolated from 
healthy control cows and cows naturally infected with M. avium subsp. paratuberculosis 
in the subclinical and clinical stages of infection. Peripheral blood mononuclear cells 
were cultured with a whole cell sonicate of MAP (10 µg/ml) for 24, 72, and 144 hr prior 
to flow cytometric measurement of ZAP70 and pZAP70. Data are presented as 
percentage of cells (mean ± SEM). Significant differences between infection group 
within a time point are designated by different letters (P < 0.05). 
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Figure 3. Expression of CTLA-4+ (A) and IFN-γ+ (B) on CD4+ T cells isolated from 
healthy control cows and cows naturally infected with M. avium subsp. paratuberculosis 
in the subclinical and clinical stages of infection. Peripheral blood mononuclear cells 
were cultured with a whole cell sonicate of MAP (10 µg/ml) for 24, 72, and 144 hr prior 
to flow cytometric measurement of ZAP70 and pZAP70.  Data are presented as 
percentage of cells (mean ± SEM). Significant differences between stage groups within a 
time point are designated by different letters (p < 0.05). 
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Figure 4. Expression of CTLA-4+ on A) CD4+ T cells. B) CD8+ T cells. C)   TCR+ T 
cells after 24 hr culture of peripheral blood mononuclear cells obtained from healthy 
control cows and cows naturally infected with M. avium subsp. paratuberculosis in the 
subclinical and clinical stages of infection. Data are presented as percentage of CTLA-
4+ cells (mean ± SEM). Significant differences between treatment groups are designated 
by asterisks *, **(P < 0.05). 
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Figure 5. Histogram demonstrating representative flow cytometric staining for surface 
expression of CTLA-4 on CD4 cells cultured with a whole cell sonicate of MAP (10 
µg/ml) for 24hr from a control non-infected cow (A), a subclinical cow (B), and a 
clinical cow (C). 
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Figure 6. Phospho flow analysis of ZAP-70 phosphorylation following T cell activation 
in CD4+, CD8+ and TCR+ cells. Significant differences between treatment groups 
are designated by different numbers of asterisks (p < 0.05). 
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CHAPTER 4: GENERAL CONCLUSION 
General Discussion 
 The study of protein complexes within the envelope of MAP yielded several 
interesting findings. This was the first study to characterize protein complexes in the 
envelope of MAP. A total of seven protein complexes were found within the envelope. 
Some complexes such as the succinate dehydrogenase complex were expected to be 
found as they have described physiological functions within the membrane, however, the 
composition of other protein complexes provided novel information.  
Major membrane protein (MAP2121c), a described antigen of MAP and other 
pathogenic mycobacterial species, was found to form a complex with a cysteine 
desulfurase protein (MAP2120c), demonstrating that these two proteins are interacting 
with each other at some level. When analyzing the antigenicity of these proteins, it was 
shown that both were highly antigenic. Major membrane protein was recognized mainly 
by clinical animals, while cysteine desulfurase was reactive to most animal sera as 
studied by Western blot. Recombinant proteins were made of both proteins, and cysteine 
desulfurase demonstrated a very high reactivity among subclinical animals, 
demonstrating potential for diagnostic development. This indicates that complex I may 
be important in the pathogenesis of MAP and contains immunodominant antigens of this 
pathogen.  
Another very interesting complex discovered was one formed with the protein 
Cfp 29 (MAP0630c). This protein was first characterized as linocin, a bacteriocin of 
Brevibacterium linens and later described to be a protein with high T cell reactivity 
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among memory effector cells isolated during the recall of protective immunity in the 
mouse model of tuberculosis infection. This protein was also found to be a T cell antigen 
of MAP with high IFN-γ response in subclinical animals. In the same complex was a 
protein of the Dyp-type peroxidase family (MAP0631c) as well as others involved in 
protein export. 
Several novel antigens were found when evaluating proteins that were identified 
by mass spectrometry in the interferon gamma release assay. These included phage 
shock protein A (MAP2855c), a putative ATPase (MAP3844) as well as Mpt64 
(MAP3290c), a major target for human tuberculosis diagnostics and previously not 
investigated for this purpose in paratuberculosis. 
The second study performed addressed the immune response of animals to MAP, 
especially differences observed in animals in clinical and subclinical stages of disease. It 
was found that ZAP-70, a molecule crucial for T cell activation, was down-regulated in 
both clinical and subclinical animals, demonstrating an alteration that occurs in T cells 
with MAP infection. This down-regulation was more pronounced among CD4+ T cells, 
but was also observed in CD8+ and  TCR + T cells. Considering the importance of 
this molecule to T cells, it is very likely that the T cells which have less or negligible 
ZAP-70 are hypofunctional and less responsive to stimulus.  
Another very interesting finding was that CD4+ T cells of subclinical animals 
expressed significantly more CTLA-4 than control non-infected cows and cows of 
clinical status. CTLA-4 is regarded as one of the major negative regulators of T cells and 
has a broad range of mechanisms to dampen immune response. However, this molecule 
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has also been shown to have a positive role in inhibiting a Th2 bias of T cells, as well as 
facilitating migration of Th1 cells to sites of infection. Both of these are possible 
functions of this molecule among subclinical animals. 
Also regarding T cells, proximal T cell receptor signaling as measured by 
phosphorylation of ZAP-70 was investigated in animals of subclinical and clinical status 
and compared to non-infected control animals. Antigen specific as well as non-specific 
stimulation was studied. Interestingly there was no change in signaling with disease state 
and animals of clinical as well as subclinical status responded well to non-specific TCR 
stimulation. This was not expected as previous research has shown that T cells animals 
in clinical stages of disease can be hypofunctional. These results, however, could be a 
function of a higher number of Treg cells within these animals, cells that have been 
demonstrated to have greater proximal T cell receptor signals in response to stimulus in 
comparison to non-Treg cells. 
Studying changes in T cells of animals infected with MAP leads to the 
conclusion that there are clear differences in T cell phenotype of infected animals (i.e. 
down-regulation of ZAP-70). Although not known exactly at this time, these alterations 
more than likely have significant impacts on the immune response of these animals. It 
was also interesting to observe clear differences between subclinical and clinical stages 
of infection (i.e. changes in CTLA-4 expression), demonstrating that these two stages do 
have some distinct immune characteristics which once better understood can lead to 
more directed approaches for vaccine and diagnostic development. 
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Recommendations for future research 
Along with several discoveries, this research also leads to more questions and 
direction for future research. Regarding envelope protein complexes it would be 
interesting to investigate the exact interaction of major membrane protein (MAP2121c) 
and cysteine desulfurase (MAP2120c), and if this is in fact a complex that would 
participate in the biosynthesis of sulfur containing co-factors as literature suggests. The 
same goes for other complexes with antigenic proteins that may be related to virulence 
such as the complex formed with Cfp 29 (MAP0630c). One possible way to address the 
complex’s function as well as its role in pathogenesis may be to delete the proteins of the 
complex and evaluate the resulting mutant. The mutant strain could be evaluated in 
relation to survival in macrophages, invasion of epithelial cells and survival in an animal 
model such as the mouse. Another possibility would be to study the mutants as a 
potential live attenuated vaccine candidate.  
Several different antigenic proteins were found within the envelope of MAP. 
This suggests potential for use of these proteins in diagnostic tests for paratuberculosis. 
Considering their antigenicity, as evidenced by results of the interferon gamma release 
assay and Western-blot, these proteins are likely also good candidates for development 
of a subunit vaccine or a vaccine with a vector such as a strain of salmonella expressing 
these proteins. 
Regarding studies of T cell responses in animals infected with MAP, several 
questions also arise. It would be very interesting to investigate the mechanism involved 
in down-regulation of ZAP-70 and if this finding is representative of a more broad 
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alteration of these cells. It would be interesting to investigate the consequence of the lack 
of ZAP-70 in these cells and measure their cytokine and proliferative responses in 
comparison to other cells. 
Also regarding ZAP-70, it was not expected that animals with clinical 
paratuberculosis would have similar and higher responses to antigen non-specific TCR 
stimulation than those of control non-infected status. This may be due to a higher 
percentage of Treg cells within these animals. This possibility could be studied by 
analyzing the responsive subset of cells and measuring markers of Treg cells such as 
Foxp3. Regarding this research it would also be interesting to investigate if MAP has the 
ability to directly inactivate ZAP-70 phosphorylation, as has been demonstrated with M. 
tuberculosis. 
It was interesting to observe such a high expression of CTLA-4 within 
subclinical animals. As was discussed before, CTLA-4 can have inhibitory functions to 
T cells, however, it could also promote a Th1 bias and enhanced migration of T cells to 
sites of infection having a positive role in subclinical animals. These are interesting 
topics to address to better understand the role of CTLA-4 in paratuberculosis.  
This further research would aid in both understanding more of the dynamics of 
the immune response to MAP as well as the role of specific proteins and protein 
complexes in the virulence of this pathogen. Hopefully coming closer to providing 
improved tools to control and prevent paratuberculosis. 
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Figure A.4 CD4+ cells cultured for 24hr and analysis of A) ZAP-70, B) pZAP-70, C) 
CTLA-4, D) IFN-γ 
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Figure A.5 CD8+ cells cultured for 24hr and analysis of A) ZAP-70, B) pZAP-70, C) 
CTLA-4, D) IFN-γ 
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Figure A.6   TCR+  cells cultured for 24hr and analysis of A) ZAP-70, B) pZAP-70, 
C) CTLA-4, D) IFN-γ 
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Figure A.7  CD4 + cells cultured for 72hr and analysis of A) ZAP-70, B) pZAP-70, C) 
CTLA-4, D) IFN-γ 
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Figure A.8  CD8 + cells cultured for 72hr and analysis of A) ZAP-70, B) pZAP-70, C) 
CTLA-4, D) IFN-γ 
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Figure A.9   TCR+  cells cultured for 72hr and analysis of A) ZAP-70, B) pZAP-70, 
C) CTLA-4, D) IFN-γ 
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Figure A.10  CD4+  cells cultured for 144hr and analysis of A) ZAP-70, B) pZAP-70, 
C) CTLA-4, D) IFN-γ 
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Figure A.11  CD8+  cells cultured for 144hr and analysis of A) ZAP-70, B) pZAP-70, 
C) CTLA-4, D) IFN-γ 
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Figure A.12   TCR+  cells cultured for 144hr and analysis of A) ZAP-70, B) pZAP-
70, C) CTLA-4, D) IFN-γ 
 
